Adverse effects, not elsewhere classified

ST19_ADVER_EFFEC_NOT_ELSEW_CLASSIFIED

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — T78 Cause of death: ICD-10 — T78 2 out of 7 registries used, show all original rules.	10364
4. Check minimum number of events None	10364
5. Include endpoints None	10364
6. Filter based on genotype QC (FinnGen only)	9330

Control definitions (FinnGen only)

Control exclude: ST19_OTHER_UNSPE_EFFEC_EXTER_CAUSES

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: T6[6-9]|T7[0-8]
Name in latin: Effectus adversi non alibi classificati

NAME	ST19_ADVER_EFFEC_NOT_ELSEW_CLASSIFIED
CONTROL_EXCLUDE	ST19_OTHER_UNSPE_EFFEC_EXTER_CAUSES
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	T78
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	T78
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Adverse effects, not elsewhere classified based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	9330	6644	2686
Unadjusted period prevalence (%)	2.03	2.36	1.23
Median age at first event (years)	47.88	45.37	54.10

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
9794: Matched controls
97932

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

R06AE09

ATC

levocetirizine; oral

2.7

319.8

2184

9486

R03AC02

ATC

salbutamol; inhalant

2.3

312.8

6373

44115

L50.9

ICD-10 Finland

Urticaria, unspecified

6.1

307.7

1111

2010

X49

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

45.6

307.7

762

181

J45.9

ICD-10 Finland

Asthma, unspecified

2.6

307.7

2559

11859

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

23.5

307.7

1305

636

X58

ICD-10 Finland

Exposure to other specified factors

3.0

307.7

2325

9286

H02AB06

ATC

prednisolone; systemic

4.3

307.7

6746

33104

L50.8

ICD-10 Finland

Other urticaria

8.5

307.7

589

730

XQ800

NOMESCO Finland

Prick test

7.8

307.7

2550

4210

T78.0

ICD-10 Finland

Anaphylactic shock due to adverse food reaction

359.7

307.7

347

X57

ICD-10 Finland

Unspecified privation

10.6

307.7

759

770

W84

ICD-10 Finland

Unspecified threat to breathing

88.0

307.7

282

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

5.7

307.7

2415

5349

T78.4

ICD-10 Finland

Allergy, unspecified

154.8

307.7

6668

1331

R06AX27

ATC

desloratadine; oral

2.5

307.7

4265

22983

C01CA24

ATC

epinephrine; parenteral

25.3

307.7

4334

2977

J45.0

ICD-10 Finland

Predominantly allergic asthma

3.4

307.7

1599

5269

T78.1

ICD-10 Finland

Other adverse food reactions, not elsewhere classified

175.2

307.7

189

L50.0

ICD-10 Finland

Allergic urticaria

7.7

307.7

858

1211

A92

ICPC

Allergy/allergic reaction NOS

5.7

307.7

937

1798

R06AE07

ATC

cetirizine; oral

3.4

307.7

6353

34613

T78.2

ICD-10 Finland

Anaphylactic shock, unspecified

456.7

307.7

2000

T78.3

ICD-10 Finland

Angioneurotic oedema

264.4

307.7

2197

107

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

6.7

307.7

917

1496

X59

ICD-10 Finland

Exposure to unspecified factor

3.9

307.7

3377

11589

H02AB07

ATC

prednisone; oral

2.9

301.5

1733

6869

R03DC03

ATC

montelukast; oral

2.5

301.4

2364

10944

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

7.7

276.3

395

533

W57

ICD-10 Finland

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

4.3

258.8

707

1741

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

2.3

255.3

2365

11693

Z51.6

ICD-10 Finland

Desensitization to allergens

7.4

254.7

376

526

R06.0

ICD-10 Finland

Dyspnoea

2.2

252.3

2977

16257

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.0

250.1

4462

28440

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.0

246.8

4656

30231

T88.6

ICD-10 Finland

Anaphylactic shock due to adverse effect of correct drug or medicament properly administered

24.6

246.1

174

J30.10

ICD-10 Finland

Allergic rhinitis due to pollen

3.0

224.2

1115

4046

N02AX02

ATC

tramadol; systemic, rectal

2.0

222.0

4295

27815

L27.2

ICD-10 Finland

Dermatitis due to ingested food

7.6

216.7

311

421

R06AX22

ATC

ebastine; oral

2.2

213.8

2200

11264

R03BA02

ATC

budesonide; inhalant

2.2

207.2

2201

11397

Z3231

NOMESCO Finland

Registered nurse

2.0

204.3

2933

17006

J01FF01

ATC

clindamycin; systemic

2.0

201.0

2939

17136

X27

ICD-10 Finland

Contact with other specified venomous animals

36.2

200.4

125

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

6.1

196.0

349

593

R60.0

ICD-10 Finland

Localized oedema

2.5

190.5

1424

6324

R06AX13

ATC

loratadine; oral

2.2

186.1

1950

9994

S01GX01

ATC

cromoglicic acid; ophthalmic

2.0

183.8

2543

14460

R51.80

ICD-10 Finland

Headache

2.1

183.3

2121

11291

XQ820

NOMESCO Finland

Exposure to medicinal substance

13.1

182.7

175

136

Y89.9

ICD-10 Finland

Sequelae of unspecified external cause

8.0

181.8

249

319

A02BC02

ATC

pantoprazole; systemic

1.9

180.5

6682

51973

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.0

180.4

2873

17137

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.9

180.3

3095

18931

XQ802

NOMESCO Finland

Epicutan test

3.4

179.3

683

2107

T63.4

ICD-10 Finland

Toxic effect: Venom of other arthropods

7.2

177.3

267

381

Y96.9

ICD-10 Finland

Unspecified type of accident

5.5

174.2

342

637

R07.4

ICD-10 Finland

Chest pain, unspecified

1.9

172.6

2774

16555

R02

ICPC

Shortness of breath/dyspnoea

2.3

169.6

1573

7647

M79.6

ICD-10 Finland

Pain in limb

1.8

168.9

4713

33349

H02AB04

ATC

methylprednisolone; systemic

2.2

168.5

1591

7790

N03AX16

ATC

[U] pregabalin

2.0

165.1

2318

13176

R03BA05

ATC

fluticasone; inhalant

2.0

165.0

2160

11978

L20.0

ICD-10 Finland

Besnier prurigo

2.4

160.3

1209

5365

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.0

158.2

2179

12280

L50.3

ICD-10 Finland

Dermatographic urticaria

4.8

156.6

362

777

E0000UV, ,

ATC

1.8

154.3

4515

32100

Y88.0

ICD-10 Finland

Sequelae of adverse effects caused by drugs, medicaments and biological substances in therapeutic use

22.0

153.1

113

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.1

152.6

1653

8519

R03AC03

ATC

terbutaline; inhalant

2.1

151.5

1608

8220

J45

ICD-10 Finland

Asthma

2.3

150.5

1333

6334

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.0

150.2

2106

11915

XF400

NOMESCO Finland

ECG with 12 standard connections

2.2

147.8

1463

7271

J01AA02

ATC

doxycycline; systemic

1.8

141.0

7397

61316

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.9

140.0

2236

13174

R01AD09

ATC

mometasone; nasal

1.7

140.0

4894

36200

XQ801

NOMESCO Finland

Intracutantest

9.6

139.8

165

175

R01AD08

ATC

fluticasone; nasal

1.8

136.7

3103

20336

AA1AD

NOMESCO Finland

CT of head and brain

1.8

135.3

2528

15628

R03AK06

ATC

salmeterol and fluticasone; inhalant

2.1

134.5

1472

7586

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.8

133.1

3029

19835

J46

ICD-10 Finland

Status asthmaticus

3.8

132.9

428

1179

R96

ICPC

Asthma

2.2

131.4

1181

5626

R60.9

ICD-10 Finland

Oedema, unspecified

2.8

129.0

679

2517

J01MA12

ATC

levofloxacin; systemic

2.0

128.3

1700

9376

J45.1

ICD-10 Finland

Nonallergic asthma

2.5

127.9

873

3684

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.7

127.0

5906

46579

Z01.8

ICD-10 Finland

Other specified special examinations

1.8

125.7

2373

14665

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

2.9

124.1

616

2211

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

3.0

123.7

594

2094

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.9

123.1

1962

11492

J01FA10

ATC

azithromycin; systemic

1.7

123.0

6105

48763

R03AK07

ATC

formoterol and budesonide; inhalant

1.8

122.7

2344

14522

R42

ICD-10 Finland

Dizziness and giddiness

1.8

122.3

2249

13773

L50.1

ICD-10 Finland

Idiopathic urticaria

7.0

121.5

185

267

WQ000

NOMESCO Finland

Hyposensibilisation

7.8

121.1

169

221

A02BC05

ATC

esomeprazole; systemic

1.7

120.7

3864

27574

M54.5

ICD-10 Finland

Low back pain

1.7

120.6

3861

27554

J01MA02

ATC

ciprofloxacin; systemic

1.7

120.2

3475

24143

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.8

119.4

2356

14718

G43.9

ICD-10 Finland

Migraine, unspecified

2.3

118.6

952

4316

Z71.8

ICD-10 Finland

Other specified counselling

1.6

115.4

3745

26732

J01DB01

ATC

cefalexin; oral

1.9

115.3

8204

71615

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.6

115.3

4185

30720

Y59

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified vaccines and biological substances

6.9

114.8

179

265

J01FA06

ATC

roxithromycin; oral

1.6

114.8

3733

26652

Y19

ICD-10 Finland

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

12.9

114.3

110

G44.2

ICD-10 Finland

Tension-type headache

1.9

114.3

1640

9258

M25.5

ICD-10 Finland

Pain in joint

1.7

113.8

3501

24633

D07AB08

ATC

desonide; topical

2.1

112.4

1214

6197

X39

ICD-10 Finland

Exposure to other and unspecified forces of nature

24.1

111.0

R4110

NOMESCO Finland

Physiotherapy

1.7

110.0

2625

17242

Z3226

NOMESCO Finland

Physiotherapist

1.9

108.9

1754

10265

S06.0

ICD-10 Finland

Concussion

2.1

108.8

1215

6274

XQ899

NOMESCO Finland

Other assessment of skin

9.5

108.3

128

136

C07AB07

ATC

bisoprolol; oral

1.6

107.8

3838

27901

D07AB02

ATC

hydrocortisone butyrate; topical

1.7

107.0

2975

20322

N02BE01

ATC

paracetamol; systemic, rectal

2.0

106.7

8666

77505

N02AJ06

ATC

codeine and paracetamol; systemic

1.6

106.5

4259

31806

P01AB01

ATC

metronidazole; oral, rectal

1.6

106.3

3983

29285

R53

ICD-10 Finland

Malaise and fatigue

1.7

106.1

2674

17794

M03BX02

ATC

tizanidine; oral

1.6

106.1

6048

49082

M54.4

ICD-10 Finland

Lumbago with sciatica

1.8

105.6

1925

11689

T78.9

ICD-10 Finland

Adverse effect, unspecified

182.0

103.5

108

D07AA02

ATC

hydrocortisone; topical

1.9

102.6

1597

9227

D07AC01

ATC

betamethasone; topical

1.6

102.4

3492

25036

J01DA01

ATC

[U] cefalexin

1.6

101.0

5830

47179

TPH04

NOMESCO Finland

Cathetrisation of vein

1.8

100.7

2055

12876

N03AX12

ATC

[U] gabapentin; oral

1.9

98.9

1539

8883

T78.8

ICD-10 Finland

Other adverse effects, not elsewhere classified

492.9

98.6

E000001, ,

ATC

1.7

96.5

2075

13172

R03BA01

ATC

beclometasone; inhalant

1.9

96.1

1381

7762

J01FA09

ATC

clarithromycin; systemic

1.6

95.8

3120

22036

N05BA04

ATC

oxazepam; oral

1.7

95.6

2573

17333

R03BB04

ATC

tiotropium bromide; inhalant

2.2

95.3

845

3980

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.9

95.2

1393

7876

Y34

ICD-10 Finland

Unspecified event, undetermined intent

7.9

95.1

130

166

W79

ICD-10 Finland

Inhalation and ingestion of food causing obstruction of respiratory tract

18.4

94.2

JN3AD

NOMESCO Finland

Abdominal CT examination

1.9

93.2

1266

6981

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.2

93.1

894

4346

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.9

92.2

1364

7733

N06AX21

ATC

duloxetine; oral

1.9

92.1

1304

7288

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.9

91.9

1399

8004

A01

ICPC

Pain general/multiple sites

2.0

91.9

1072

5606

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.8

90.9

1588

9478

R01AD12

ATC

fluticasone furoate; nasal

1.6

90.8

3445

25143

R20.2

ICD-10 Finland

Paraesthesia of skin

2.2

90.4

860

4163

N05BB01

ATC

hydroxyzine; systemic

2.4

90.3

695

3082

J30.3

ICD-10 Finland

Other allergic rhinitis

2.7

89.6

508

1951

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.1

89.0

993

5106

M03BC01

ATC

orphenadrine (citrate); systemic

1.7

88.9

2252

14890

R50.9

ICD-10 Finland

Fever, unspecified

1.8

88.8

1573

9419

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.0

88.4

1112

5966

Y98

ICD-10 Finland

Lifestyle-related condition

12.0

88.3

R01AD58

ATC

fluticasone, combinations; nasal

1.6

87.8

2814

19715

R05

ICPC

Cough

1.6

87.3

2621

18071

L03

ICPC

Low back symptom/complaint

1.6

87.2

3018

21520

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.6

87.1

2732

19035

ZXD10

NOMESCO Finland

Scheduled procedure

1.6

86.5

3350

24496

ZXE00

NOMESCO Finland

One hour or less

1.5

86.5

3640

27112

D07AC13

ATC

mometasone; topical

1.6

86.2

2702

18814

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.6

86.0

2835

19974

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.7

85.9

2113

13849

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.1

85.6

897

4504

Z2221

NOMESCO Finland

Medical doctor

1.6

85.2

2634

18270

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.8

85.1

1349

7802

R06.4

ICD-10 Finland

Hyperventilation

4.0

85.0

242

610

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.1

84.5

919

4677

A02BA02

ATC

ranitidine; systemic

1.8

83.7

1550

9391

L27.0

ICD-10 Finland

Generalized skin eruption due to drugs and medicaments

4.6

83.2

202

451

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.9

82.2

1095

5984

R11

ICD-10 Finland

Nausea and vomiting

2.0

81.6

988

5223

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.9

81.3

1106

6084

J02AC01

ATC

fluconazole; systemic

1.5

81.3

4061

31255

J01MA14

ATC

moxifloxacin; systemic

2.1

81.0

837

4177

C08CA01

ATC

amlodipine; oral

1.6

79.7

2856

20439

N05BA01

ATC

diazepam; systemic, rectal

1.9

79.5

1158

6511

317

Kela drug reimbursment

Topical pimecrolimus and tacrolimus

3.7

79.4

260

723

WX408

NOMESCO Finland

General anesthesy, balanced

1.6

79.4

2348

16068

R03AK08

ATC

formoterol and beclometasone; inhalant

2.5

78.8

517

2130

R74

ICPC

Upper respiratory infection acute

1.5

78.8

3841

29353

M79.7

ICD-10 Finland

Fibromyalgia

2.6

78.1

468

1846

R03AC13

ATC

formoterol; inhalant

2.5

78.0

512

2110

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.9

77.2

1057

5821

UJF32

NOMESCO Finland

Coloscopy

1.6

77.2

2178

14720

M79.1

ICD-10 Finland

Myalgia

1.7

76.8

1613

10102

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.5

76.8

3047

22263

C03CA01

ATC

furosemide; systemic

1.6

76.7

2000

13254

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.8

76.7

386

1392

WX002

NOMESCO Finland

Sedation and analgesia

1.7

76.3

1627

10228

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.8

76.3

1367

8184

S29

ICPC

Skin symptom/complaint other

1.6

75.9

2009

13360

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.9

75.8

1028

5643

T74.1

ICD-10 Finland

Physical abuse

4.2

75.6

203

490

A02BC01

ATC

omeprazole; systemic

1.6

75.3

2389

16586

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.2

75.2

695

3319

L17

ICPC

Foot/toe symptom/complaint

1.5

74.8

2938

21389

N06AX16

ATC

venlafaxine; oral

1.7

74.7

1528

9493

ZXE10

NOMESCO Finland

More than one and less than three hours

1.5

74.4

3068

22565

K30

ICD-10 Finland

Functional dyspepsia

1.8

74.0

1187

6869

D01

ICPC

Abdominal pain/cramps general

1.7

74.0

1442

8837

S18

ICPC

Laceration/cut

1.5

73.9

4154

32540

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.8

73.8

1333

7992

N05AH04

ATC

quetiapine; oral

1.7

73.7

1819

11872

R03BA08

ATC

ciclesonide; inhalant

2.0

73.6

912

4853

WX892

NOMESCO Finland

Monitored bed care

2.2

73.3

689

3312

A03

ICPC

Fever

1.6

73.2

1998

13369

N06AX11

ATC

mirtazapine; oral

1.5

73.2

3198

23791

J45.8

ICD-10 Finland

Mixed asthma

2.9

72.9

361

1290

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.7

72.4

1478

9170

L12

ICPC

Hand/finger symptom/complaint

1.6

71.8

1821

11959

H01

ICPC

Ear pain/earache

1.7

71.7

1403

8602

A06AC01

ATC

ispaghula (psylla seeds); oral

1.6

71.5

2297

15965

R00.2

ICD-10 Finland

Palpitations

2.0

71.3

902

4832

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.5

71.3

4550

36447

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.8

70.9

1335

8095

R52.9

ICD-10 Finland

Pain, unspecified

1.9

70.8

1073

6097

N03AX09

ATC

lamotrigine; oral

2.2

70.8

610

2831

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.8

70.2

1146

6662

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

2.6

70.0

429

1710

XF600

NOMESCO Finland

Bloodpressure measurement

2.2

69.9

617

2891

R07.3

ICD-10 Finland

Other chest pain

1.9

69.9

979

5424

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

69.8

4069

31983

N30.0

ICD-10 Finland

Acute cystitis

1.6

69.7

1809

11939

D11

ICPC

Diarrhoea

1.7

69.6

1377

8461

R01BA52

ATC

pseudoephedrine, combinations; oral

1.5

69.5

2641

19031

R06AX26

ATC

fexofenadine; oral

2.0

69.3

777

3989

R03AC12

ATC

salmeterol; inhalant

2.6

68.1

414

1643

A02BC03

ATC

lansoprazole; oral

1.6

67.9

2326

16373

H53.1

ICD-10 Finland

Subjective visual disturbances

2.0

67.3

741

3777

A03FA01

ATC

metoclopramide; systemic, rectal

1.6

67.2

2044

13999

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

2.3

66.3

525

2350

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.7

66.3

1603

10378

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.7

65.8

1391

8694

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.9

65.4

954

5350

A04

ICPC

Weakness/tiredness general

1.6

65.3

1631

10644

G47.3

ICD-10 Finland

Sleep apnoea

1.6

64.6

1944

13265

M01AE02

ATC

naproxen; oral, rectal

1.4

64.3

5475

45915

WX110

NOMESCO Finland

Infiltration anesthesia

1.5

64.0

7076

62306

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.8

63.9

1036

6000

R21

ICPC

Throat symptom/complaint

1.5

63.8

2556

18562

N06AB04

ATC

citalopram; systemic

1.6

63.8

1867

12652

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.4

62.9

5290

44180

L28

ICPC

Limited function/disability (L)

1.7

62.8

1495

9631

N05CF01

ATC

zopiclone; oral

1.5

62.7

2608

19076

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.3

62.6

513

2330

J20

ICD-10 Finland

Acute bronchitis

1.8

62.3

1050

6149

N01

ICPC

Headache

1.7

62.2

1426

9094

A46

ICD-10 Finland

Erysipelas

1.7

61.6

1147

6915

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.9

61.1

847

4668

D11AH01

ATC

tacrolimus; topical

4.1

61.1

171

426

K08.80

ICD-10 Finland

Toothache NOS

1.8

61.0

1000

5806

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.5

60.9

2951

22228

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.0

60.8

753

3998

R06.2

ICD-10 Finland

Wheezing

2.3

60.7

502

2288

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.6

60.7

367

1453

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.9

60.6

888

4981

F43.1

ICD-10 Finland

Post-traumatic stress disorder

2.5

60.4

398

1641

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.8

60.4

949

5440

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.8

60.2

918

5215

R01AD05

ATC

budesonide; nasal

2.0

60.1

728

3834

N02AA05

ATC

oxycodone; systemic

1.7

60.0

1323

8348

S80.0

ICD-10 Finland

Contusion of knee

1.9

59.7

840

4652

L50

ICD-10 Finland

Urticaria

3.0

59.1

272

933

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.7

59.0

1275

7997

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.8

59.0

965

5597

X12

ICD-10 Finland

Contact with other hot fluids

5.5

58.5

114

211

L01

ICPC

Neck symptom/complaint

1.6

58.1

1682

11342

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

2.1

58.0

610

3055

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.7

57.9

1188

7347

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.9

57.8

783

4281

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.8

57.2

857

4838

SAA01

NOMESCO Finland

Simple examination of mouth

1.5

57.0

7182

63937

C07AA05

ATC

propranolol; systemic

1.5

57.0

1968

13799

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.0

57.0

639

3275

M01AB05

ATC

diclofenac; systemic, rectal

1.4

56.6

5891

50625

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.7

56.5

1090

6628

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.8

56.4

967

5685

R55

ICD-10 Finland

Syncope and collapse

1.8

56.3

899

5175

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.3

56.1

425

1865

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

2.2

55.9

515

2451

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

1.9

55.8

777

4284

N06AB10

ATC

escitalopram; oral

1.5

55.8

2140

15331

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.3

55.8

448

2016

R05

ICD-10 Finland

Cough

1.5

55.8

2050

14556

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.6

55.2

1335

8609

D20

ICPC

Mouth/tongue/lip symptom/complaint

2.1

55.0

524

2526

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.5

55.0

2353

17229

A11

ICPC

Chest pain NOS

1.9

54.7

760

4186

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.9

54.7

808

4538

XG474

NOMESCO Finland

Exhalation nntrogen oxide

2.7

54.7

302

1142

B02AA02

ATC

tranexamic acid; systemic

1.6

54.7

1469

9719

WZC30

NOMESCO Finland

Teaching

1.6

54.4

1412

9265

W19

ICD-10 Finland

Unspecified fall

1.8

54.2

889

5156

R52.2

ICD-10 Finland

Other chronic pain

2.4

54.0

398

1726

E000002, ,

ATC

1.7

53.7

1109

6863

SPAT1254

SPAT

Administration of medicine

1.6

53.4

1298

8377

H10.1

ICD-10 Finland

Acute atopic conjunctivitis

2.5

53.3

339

1374

D06

ICPC

Abdominal pain localized other

1.7

53.1

979

5871

Z00.8

ICD-10 Finland

Other general examinations

1.8

52.7

795

4494

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

2.1

52.6

543

2698

344

Kela drug reimbursment

Omalizumab

10.6

52.3

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.7

52.2

1206

7680

J31.0

ICD-10 Finland

Chronic rhinitis

1.8

52.2

875

5104

R07.0

ICD-10 Finland

Pain in throat

1.8

51.8

856

4972

M01AH05

ATC

etoricoxib; oral

1.4

51.8

5662

48694

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.3

51.8

401

1777

R00.0

ICD-10 Finland

Tachycardia, unspecified

2.2

51.7

457

2139

J01EA01

ATC

trimethoprim; systemic

1.5

51.6

2354

17418

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

4.6

51.6

122

267

ZY010

NOMESCO Finland

Hospital outpatient

2.0

51.4

597

3096

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.6

51.3

1231

7914

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

2.1

50.9

503

2458

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

50.9

5044

42640

Y96.8

ICD-10 Finland

Other type of accident

4.9

50.8

112

231

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.3

50.5

376

1638

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.4

50.4

2904

22411

S21

ICPC

Skin texture symptom/complaint

1.6

50.3

1387

9218

J01FA01

ATC

erythromycin; systemic

1.6

50.3

1391

9252

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.0

50.2

604

3170

N17

ICPC

Vertigo/dizziness

1.7

50.1

1133

7174

M03BC51

ATC

orphenadrine, combinations; systemic

1.5

49.9

2391

17835

H57.1

ICD-10 Finland

Ocular pain

2.2

49.9

456

2162

W99

ICD-10 Finland

Exposure to other and unspecified man-made environmental factors

6.3

49.9

135

D02

ICPC

Abdominal pain epigastric

1.9

49.8

669

3642

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.0

49.8

581

3016

P01

ICPC

Feeling anxious/nervous/tense

1.5

49.5

1608

11085

Z00.0

ICD-10 Finland

General medical examination

1.5

49.5

1756

12338

I10

ICD-10 Finland

Essential (primary) hypertension

1.4

49.3

4411

36607

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.4

49.3

2619

19907

R13

ICD-10 Finland

Dysphagia

1.9

49.1

606

3207

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.1

49.0

489

2399

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.9

48.9

624

3341

R01AD01

ATC

beclometasone; nasal

1.6

48.7

1360

9059

L02

ICPC

Back symptom/complaint

1.7

48.5

1095

6926

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.8

48.2

820

4800

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.5

48.2

1646

11464

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.4

48.0

2582

19653

A12

ICPC

ALLERGY/ALLERGIC REACTION

6.7

47.8

112

M70.6

ICD-10 Finland

Trochanteric bursitis

1.6

47.7

1157

7447

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.7

47.5

1047

6580

E000003, ,

ATC

2.2

47.4

432

2047

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.0

47.1

534

2745

F29

ICPC

Eye symptom/complaint other

1.7

47.0

1040

6542

WX402

NOMESCO Finland

General anaesthesia

1.5

46.9

2074

15209

M01AE03

ATC

ketoprofen; systemic, rectal

1.4

46.5

2884

22476

J01DA09

ATC

[U] cefadroxil

1.4

46.3

2335

17546

G43.3

ICD-10 Finland

Complicated migraine

2.7

46.1

250

937

E66.8

ICD-10 Finland

Other obesity

1.9

45.9

604

3264

D07AD01

ATC

clobetasol; topical

1.5

45.8

1466

10058

A10BA02

ATC

metformin; oral

1.5

45.8

2025

14843

C03DA01

ATC

spironolactone; oral

1.7

45.7

883

5356

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.7

45.4

817

4858

A29

ICPC

General symptom/complaint other

1.6

45.3

1152

7498

R03DX05

ATC

omalizumab; parenteral

10.7

45.2

U02

ICPC

Urinary frequency/urgency

1.5

45.1

1393

9481

L15

ICPC

Knee symptom/complaint

1.4

45.1

2256

16914

ZXD05

NOMESCO Finland

Urgent procedure

1.4

45.0

2618

20157

UJF30

NOMESCO Finland

Ileoscopy through colon

1.7

44.9

933

5771

J05AB01

ATC

aciclovir; systemic

1.5

44.7

1966

14387

T75.4

ICD-10 Finland

Effects of electric current

7.3

44.4

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

2.1

44.4

431

2092

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.6

44.3

1178

7747

A08

ICPC

Swelling

2.0

44.2

478

2415

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.9

44.1

626

3466

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.8

43.4

731

4262

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.5

43.3

1522

10641

501

Kela drug reimbursment

Cow's milk and / or soy protein allergy in young children

3.6

43.3

146

415

A01AB09

ATC

miconazole; local oral

1.8

43.1

709

4105

UKC02

NOMESCO Finland

Cystoscopy

1.6

43.1

1048

6743

N89

ICPC

Migraine

2.0

43.1

504

2618

XF404

NOMESCO Finland

Ambulatory ECG

1.8

42.6

657

3732

ZXA00

NOMESCO Finland

Right side

1.5

42.6

1902

13940

E000006, ,

ATC

1.9

42.5

601

3323

Y94.0

ICD-10 Finland

Accident at home

3.1

42.4

180

590

L16

ICPC

Ankle symptom/complaint

1.6

42.0

1196

7985

A99

ICPC

Disease/condition unspecnature/site

1.7

41.7

931

5859

S01GX02

ATC

levocabastine; ophthalmic

1.9

41.7

580

3190

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.8

41.7

688

3987

J02.9

ICD-10 Finland

Acute pharyngitis, unspecified

1.8

41.7

709

4145

N06AB06

ATC

sertraline; oral

1.6

41.6

1141

7548

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.4

41.6

3505

28568

R4120

NOMESCO Finland

Occupational therapy

1.9

41.6

586

3237

H04.10

ICD-10 Finland

Dry eye syndrome

1.6

41.3

1098

7213

B01AB05

ATC

enoxaparin; parenteral

1.4

41.2

2437

18767

S02

ICPC

Pruritus

2.1

41.1

388

1862

R01AD11

ATC

triamcinolone; nasal

1.7

41.1

770

4627

WZC00

NOMESCO Finland

Treatment plan or consultation

1.4

41.0

3425

27866

S01GX08

ATC

ketotifen; ophthalmic

2.0

40.9

496

2607

R29

ICPC

Respiratory symptom/complaint other

1.8

40.8

652

3743

E66.01

ICD-10 Finland

Obesity due to excess calories

1.6

40.6

996

6416

W22

ICD-10 Finland

Striking against or struck by other object(s)

1.8

40.6

613

3459

H92.0

ICD-10 Finland

Otalgia

1.8

40.6

699

4101

D11AH02

ATC

pimecrolimus; topical

5.0

40.5

172

J01DC02

ATC

cefuroxime; systemic

1.9

40.5

518

2772

N02BF02

ATC

pregabalin; oral

1.8

40.4

629

3582

T90

ICPC

Diabetes non-insulin dependent

1.5

40.4

1687

12194

J01MA06

ATC

norfloxacin; oral

1.6

40.3

1042

6797

M01AG02

ATC

tolfenamic acid; oral, rectal

1.5

40.1

1375

9551

Z2446

NOMESCO Finland

Social worker

1.8

40.0

616

3496

ZXA10

NOMESCO Finland

Bilateral

1.5

40.0

1431

10027

R4190

NOMESCO Finland

Nutritional therapy

2.0

39.8

430

2170

Z2445

NOMESCO Finland

Psychologist

2.0

39.8

436

2213

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.4

39.7

2071

15589

J04.0

ICD-10 Finland

Acute laryngitis

2.0

39.7

455

2346

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.4

39.7

2241

17103

L23.3

ICD-10 Finland

Allergic contact dermatitis due to drugs in contact with skin

4.5

39.5

215

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.9

39.5

540

2953

N71.0

ICD-10 Finland

Acute inflammatory disease of uterus

2.2

39.5

340

1574

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.4

39.4

1739

12696

M54.2

ICD-10 Finland

Cervicalgia

1.7

39.4

756

4571

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.1

39.4

386

1880

R03DA04

ATC

theophylline; systemic, rectal

2.2

39.3

354

1668

N30.9

ICD-10 Finland

Cystitis, unspecified

1.8

39.3

634

3648

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.5

39.2

1445

10186

L08

ICPC

Shoulder symptom/complaint

1.4

39.1

1955

14600

J01DA06

ATC

[U] cefuroxime

1.5

39.0

1199

8134

D07CC01

ATC

betamethasone and antibiotics; topical

1.6

38.9

1044

6866

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.6

38.8

1030

6756

ZYC01

NOMESCO Finland

Remote contact by phone

1.8

38.6

590

3340

X48

ICD-10 Finland

Accidental poisoning by and exposure to pesticides

56.5

38.3

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

1.9

38.3

497

2673

K02.1

ICD-10 Finland

Caries of dentine

1.3

38.2

5743

50651

Z02.7

ICD-10 Finland

Issue of medical certificate

1.8

38.2

666

3919

R12

ICD-10 Finland

Heartburn

1.7

38.2

802

4966

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.3

38.2

291

1281

D11AX14

ATC

[U] tacrolimus

4.9

38.0

174

N03AE01

ATC

clonazepam; systemic

1.9

37.9

477

2538

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.5

37.9

1213

8295

R51

ICD-10 Finland

Headache

1.8

37.9

622

3597

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.7

37.7

732

4438

C09CA06

ATC

candesartan; oral

1.4

37.7

1986

14955

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

2.9

37.6

178

621

J30.19

ICD-10 Finland

Pollen allergy UNS

1.9

37.6

486

2610

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.8

37.5

635

3705

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.6

37.5

954

6195

S04

ICPC

Lump/swelling localized

1.6

37.4

1055

7015

Z88.6

ICD-10 Finland

Personal history of allergy to analgesic agent

9.2

37.4

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.0

37.3

425

2186

C07AB02

ATC

metoprolol; systemic

1.5

37.2

1288

8955

S01

ICPC

Pain/tenderness of skin

2.0

37.2

438

2280

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.1

37.1

343

1633

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

1.9

37.1

490

2649

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.8

37.1

624

3634

N02BF01

ATC

gabapentin; oral

1.6

37.1

913

5882

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.7

36.9

795

4953

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.1

36.9

357

1730

Z01.7

ICD-10 Finland

Laboratory examination

1.5

36.8

1525

10984

ZXA05

NOMESCO Finland

Left side

1.4

36.8

1742

12862

A97

ICPC

No disease

1.4

36.8

1843

13746

W64

ICD-10 Finland

Exposure to other and unspecified animate mechanical forces

4.0

36.6

105

267

SPAT1260

SPAT

Consultation of another employee

1.5

36.3

1459

10445

TQW80

NOMESCO Finland

Local dermatologic skincare

2.4

36.3

244

1016

M01AH01

ATC

celecoxib; oral

1.5

36.2

1348

9505

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.6

36.2

858

5475

M54

ICD-10 Finland

Dorsalgia

1.5

36.2

1202

8281

SPAT1283

SPAT

Restricted health certificate

1.4

36.1

1928

14536

F45.8

ICD-10 Finland

Other somatoform disorders

1.7

36.1

748

4613

R10.0

ICD-10 Finland

Acute abdomen

2.2

36.0

316

1475

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

2.0

36.0

380

1903

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.9

35.9

484

2635

K59.09

ICD-10 Finland

Constipation, unspecified

1.8

35.9

546

3087

M13.9

ICD-10 Finland

Arthritis, unspecified

1.7

35.7

647

3849

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.8

35.6

602

3511

ZX120

NOMESCO Finland

Intravenous

1.7

35.6

743

4591

338

Kela drug reimbursment

C1-esterase inhibitor, icatibant and conestat alfa

+∞

35.4

N06AA09

ATC

amitriptyline; systemic

1.7

35.4

711

4348

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.8

35.4

587

3404

M54.6

ICD-10 Finland

Pain in thoracic spine

1.7

35.3

721

4430

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

2.8

35.2

183

672

K10.3

ICD-10 Finland

Alveolitis of jaws

1.8

35.2

501

2775

A28

ICPC

Limited function/disability NOS

1.5

35.2

1142

7828

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.7

35.0

691

4205

SPAT1263

SPAT

Sampling

1.3

34.9

3703

30978

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.6

34.7

883

5730

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.4

34.6

2119

16333

R83

ICPC

Respiratory infection other

1.3

34.6

2718

21777

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.5

34.6

1104

7538

K59.1

ICD-10 Finland

Functional diarrhoea

1.8

34.5

504

2813

M35.7

ICD-10 Finland

Hypermobility syndrome

2.7

34.5

193

736

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.4

34.4

1702

12652

395

Kela drug reimbursment

Dupilumab

6.8

34.3

A06AD11

ATC

lactulose; oral

1.6

34.2

974

6484

M04AA01

ATC

allopurinol; systemic

1.6

34.2

762

4785

D02AX

ATC

Other emollients and protectives

2.1

34.2

326

1571

M94.0

ICD-10 Finland

Chondrocostal junction syndrome [Tietze]

2.3

34.2

251

1087

S63.5

ICD-10 Finland

Sprain and strain of wrist

2.0

34.1

402

2092

Z50.1

ICD-10 Finland

Other physical therapy

1.9

34.1

422

2233

Z01.2

ICD-10 Finland

Dental examination

1.3

34.0

4590

39619

SFA30

NOMESCO Finland

Three-surface restoration

1.3

34.0

3609

30167

L29

ICPC

Musculoskeletal sympt/complt other

1.6

33.9

785

4977

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.4

33.9

1715

12794

J30.4

ICD-10 Finland

Allergic rhinitis, unspecified

1.9

33.9

423

2245

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

2.5

33.9

211

848

S83.6

ICD-10 Finland

Sprain and strain of other and unspecified parts of knee

1.8

33.9

539

3088

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

1.9

33.8

454

2467

SFA20

NOMESCO Finland

Two-surface restoration

1.3

33.8

5514

48767

P06

ICPC

Sleep disturbance

1.5

33.8

1248

8778

A07AA02

ATC

nystatin; oral

1.9

33.7

449

2434

U01

ICPC

Dysuria/painful urination

1.6

33.6

776

4916

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.8

33.6

578

3387

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.6

33.6

926

6120

J01FA15

ATC

telithromycin; oral

1.6

33.6

811

5196

ZXX01

NOMESCO Finland

Extent of proceudre, 1 unit

3.9

33.4

249

M02AA07

ATC

piroxicam; topical

1.3

33.4

2639

21140

D02AE01

ATC

carbamide; topical

1.8

33.4

551

3190

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.4

33.4

1655

12301

R51.81

ICD-10 Finland

Facial pain NOS

2.3

33.3

254

1118

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.4

33.3

1499

10946

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.8

33.3

489

2734

R97

ICPC

Allergic rhinitis

2.3

33.2

257

1139

J05AB11

ATC

valaciclovir; oral

1.5

33.2

1275

9038

L23.9

ICD-10 Finland

Allergic contact dermatitis, unspecified cause

3.4

33.1

120

358

WVA20

NOMESCO Finland

Medicine administration

2.3

33.0

254

1123

P03

ICPC

Feeling depressed

1.5

33.0

1133

7851

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.7

32.9

583

3444

L04AX03

ATC

methotrexate; systemic

1.6

32.7

837

5437

D09

ICPC

Nausea

1.8

32.6

534

3084

N05CF02

ATC

zolpidem; oral

1.4

32.6

1452

10580

J01.9

ICD-10 Finland

Acute sinusitis, unspecified

1.9

32.6

457

2518

P76

ICPC

Depressive disorder

1.6

32.6

726

4558

WX290

NOMESCO Finland

Other blockage of nerve

1.3

32.6

4682

40649

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.4

32.5

2293

18042

D10

ICPC

Vomiting

1.7

32.5

689

4271

R05FB02

ATC

cough suppressants and expectorants; systemic

1.3

32.5

2782

22527

L20

ICD-10 Finland

Atopic dermatitis

2.0

32.5

373

1924

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.6

32.5

758

4815

XG410

NOMESCO Finland

Flow-volume spirometry

2.1

32.4

318

1550

C08CA13

ATC

lercanidipine; oral

1.5

32.4

969

6520

WZA90

NOMESCO Finland

Other medical or dental certificate

1.4

32.2

2127

16564

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.4

32.1

1840

14004

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.8

32.1

500

2845

6918B

ICD-9 Finland

Atopic dermatitis and related conditions, Other atopic dermatitis and related conditions[ECZEMA ATOPICUM]

3.5

32.1

112

326

P74

ICPC

Anxiety disorder/anxiety state

1.8

32.1

532

3084

GX1L5

NOMESCO Finland

Exhaled nitric oxide analysis

3.5

32.0

112

327

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.6

31.9

886

5862

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

1.9

31.8

388

2044

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

2.0

31.8

358

1835

U07

ICPC

Urine symptom/complaint other

1.6

31.6

692

4324

D06AX01

ATC

fusidic acid; topical

1.6

31.6

798

5164

P29

ICPC

Psychological sympt/compl other

1.6

31.6

842

5519

I20.09

ICD-10 Finland

Unstable angina

2.0

31.6

337

1694

N03AG01

ATC

valproic acid; systemic, rectal

1.8

31.6

507

2912

103

Kela drug reimbursment

Diabetes, insulin-treated

1.4

31.5

1785

13554

R05FA02

ATC

opium derivatives and expectorants; systemic

1.3

31.5

3231

26805

K80

ICPC

Cardiac arrhythmia NOS

1.6

31.5

686

4283

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.5

31.4

941

6332

R01AC01

ATC

cromoglicic acid; nasal

2.0

31.3

372

1942

B06AC02

ATC

icatibant; parenteral

+∞

31.3

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.3

31.1

3574

30081

H02AB09

ATC

hydrocortisone; systemic

2.3

31.0

244

1089

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.9

31.0

414

2247

L23.6

ICD-10 Finland

Allergic contact dermatitis due to food in contact with skin

9.3

30.9

B01AC04

ATC

clopidogrel; oral

1.5

30.9

933

6288

N06AX26

ATC

vortioxetine; oral

1.6

30.8

767

4945

R5140

NOMESCO Finland

Monitoring the use of the aid

1.6

30.8

812

5306

G43

ICD-10 Finland

Migraine

1.7

30.7

643

3972

GD1AA, ,

SPAT

1.4

30.7

1542

11471

K52.2

ICD-10 Finland

Allergic and dietetic gastroenteritis and colitis

3.6

30.4

100

280

A03FA02

ATC

cisapride; oral, rectal

1.7

30.3

530

3119

J01CA04

ATC

amoxicillin; systemic

1.4

30.3

7899

73836

K04

ICPC

Palpitations/awareness of heart

1.8

30.3

474

2702

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.8

30.2

473

2695

C09AA02

ATC

enalapril; systemic

1.5

30.2

1169

8287

SPAT1310

SPAT

Counselling related to known health issue

1.3

30.2

2702

21971

D11AH05

ATC

dupilumab; topical

6.1

30.1

XF402

NOMESCO Finland

ECG with work load test

1.6

30.1

687

4338

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.1

30.1

280

1338

L04

ICPC

Chest symptom/complaint

1.7

29.9

570

3435

L20

ICPC

Joint symptom/complaint NOS

1.9

29.9

362

1902

D84.11

ICD-10 Finland

Hereditary angioedema type I

303.4

29.8

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.6

29.7

661

4146

D84.13

ICD-10 Finland

Hereditary angioedema type III

155.5

29.7

L30.3

ICD-10 Finland

Infective dermatitis

2.0

29.6

308

1534

SFA10

NOMESCO Finland

One-surface restoration

1.3

29.6

5202

46078

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.5

29.6

1039

7225

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

2.0

29.6

346

1797

L13

ICPC

Hip symptom/complaint

1.4

29.5

1501

11181

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.5

29.5

1026

7120

XQ830

NOMESCO Finland

Exposure to foodstuff

9.0

29.4

4930A

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]

3.2

29.4

114

355

L14

ICPC

Leg/thigh symptom/complaint

1.6

29.3

689

4382

N05BA12

ATC

alprazolam; oral

1.6

29.3

775

5069

Y94.8

ICD-10 Finland

Other leisure activity accident

2.2

29.2

251

1162

K04.08

ICD-10 Finland

Other specified pulpit

1.6

29.2

768

5016

M89.0

ICD-10 Finland

Algoneurodystrophy

3.4

29.2

106

317

V01AA05

ATC

tree pollen; parenteral

3.4

29.2

106

317

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.5

29.2

1061

7427

O47.0

ICD-10 Finland

False labour before 37 completed weeks of gestation

1.5

29.1

861

5772

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.7

29.1

496

2897

H66.9

ICD-10 Finland

Otitis media, unspecified

1.6

29.1

743

4820

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.8

29.1

435

2446

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.4

29.0

1239

8945

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.7

29.0

499

2923

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.4

29.0

1297

9445

SPAT1211

SPAT

Application of soft bandage

1.6

28.9

715

4603

C09AA05

ATC

ramipril; oral

1.4

28.9

1493

11150

J03.9

ICD-10 Finland

Acute tonsillitis, unspecified

1.7

28.9

589

3614

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.7

28.8

522

3103

F41.1

ICD-10 Finland

Generalized anxiety disorder

1.7

28.8

612

3796

S60.0

ICD-10 Finland

Contusion of finger(s) without damage to nail

1.9

28.7

360

1914

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

1.8

28.7

425

2383

A02BC04

ATC

rabeprazole; oral

1.6

28.6

739

4804

S01GX09

ATC

olopatadine; ophthalmic

2.1

28.6

281

1371

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.7

28.6

506

2988

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.3

28.5

2610

21252

M10.9

ICD-10 Finland

Gout, unspecified

1.8

28.5

418

2335

V49.9

ICD-10 Finland

Car occupant [any] injured in unspecified traffic accident

1.9

28.5

348

1833

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.4

28.5

1887

14664

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

2.1

28.5

258

1220

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.5

28.5

1105

7833

M54.3

ICD-10 Finland

Sciatica

1.7

28.4

495

2911

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.1

28.4

268

1288

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.5

28.3

952

6556

L23.0

ICD-10 Finland

Allergic contact dermatitis due to metals

3.1

28.3

120

394

S98

ICPC

Urticaria

3.5

28.3

289

S88

ICPC

Dermatitis contact/allergic

2.3

28.3

219

971

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.0

28.2

308

1562

S89.9

ICD-10 Finland

Unspecified injury of lower leg

1.9

28.1

348

1842

R33

ICD-10 Finland

Retention of urine

1.8

28.1

455

2619

G43.8

ICD-10 Finland

Other migraine

2.4

28.0

193

814

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

1.9

27.8

385

2113

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

1.9

27.8

381

2085

SPAT1104

SPAT

Monitoring of emergency patient

1.7

27.8

484

2845

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.6

27.8

620

3892

K04.0

ICD-10 Finland

Pulpitis

1.5

27.7

860

5824

JAH01

NOMESCO Finland

Laparoscopy

1.8

27.7

420

2371

WX006

NOMESCO Finland

Intravenous sedation or analgesia without general anesthesia

1.7

27.5

540

3278

R03BC01

ATC

cromoglicic acid; inhalant

2.6

27.5

158

612

W49

ICD-10 Finland

Exposure to other and unspecified inanimate mechanical forces

2.6

27.4

164

647

R25.2

ICD-10 Finland

Cramp and spasm

2.2

27.4

224

1016

R56.8

ICD-10 Finland

Other and unspecified convulsions

1.8

27.4

416

2349

Z3229

NOMESCO Finland

Other healthcare associate professional

1.6

27.3

610

3828

K07

ICPC

Swollen ankles/oedema

1.9

27.3

327

1712

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.6

27.2

704

4577

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.3

27.2

206

905

F51.0

ICD-10 Finland

Nonorganic insomnia

1.4

27.2

1665

12770

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.4

27.1

1141

8207

N06AX12

ATC

bupropion; oral

1.6

27.0

741

4883

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.6

27.0

688

4460

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.3

26.9

1933

15193

S76

ICPC

Skin infection other

1.8

26.8

435

2505

M54.1

ICD-10 Finland

Radiculopathy

1.9

26.8

336

1786

ZXE20

NOMESCO Finland

More than three and less than five hours

1.5

26.8

929

6438

Z01.9

ICD-10 Finland

Special examination, unspecified

1.7

26.6

499

2993

N30

ICD-10 Finland

Cystitis

1.5

26.5

815

5507

L23.2

ICD-10 Finland

Allergic contact dermatitis due to cosmetics

3.0

26.5

114

378

H53.9

ICD-10 Finland

Visual disturbance, unspecified

1.9

26.5

337

1801

M01AX17

ATC

nimesulide; oral

1.4

26.4

1610

12332

SGA01

NOMESCO Finland

Emergency treatment

1.4

26.3

1477

11165

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

2.2

26.3

216

982

T82

ICPC

Obesity

1.8

26.3

422

2422

L11

ICPC

Wrist symptom/complaint

1.5

26.3

902

6235

69100

ICD-8 Finland

Infantile eczema and related conditions, Eczema atopicum. Prurigo Besnier. Eczema pruriginosum allergicum

2.8

26.3

132

477

SPAT1255

SPAT

Intravenous administration of medicine

1.7

26.2

487

2913

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

2.0

26.2

293

1498

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.7

26.2

473

2808

4939X

ICD-9 Finland

Asthma, unspecified[ASTHMA BRONCHIALE NUD]

2.7

26.1

138

512

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.5

26.1

848

5796

R09

ICPC

Sinus symptom/complaint

1.5

26.1

825

5607

EBA00

NOMESCO Finland

Extraction of tooth

1.3

26.1

3273

27688

L29.9

ICD-10 Finland

Pruritus, unspecified

2.1

26.1

264

1303

N76.0

ICD-10 Finland

Acute vaginitis

1.5

25.9

755

5041

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.6

25.9

558

3470

N06AB03

ATC

fluoxetine; oral

1.5

25.9

1008

7143

H03AA01

ATC

levothyroxine sodium; systemic

1.3

25.8

1917

15127

KH1AD

NOMESCO Finland

CT of urinary organs

2.0

25.7

280

1418

C07AB12

ATC

nebivolol; oral

2.1

25.7

231

1089

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.6

25.7

580

3650

R03BC03

ATC

nedocromil; inhalant

1.7

25.7

516

3153

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.7

25.6

514

3139

C08DA01

ATC

verapamil; systemic

2.0

25.5

288

1477

WXQ27

NOMESCO Finland

UVB narrow spectrum light therapy

2.8

25.5

127

457

S12

ICPC

Insect bite/sting

1.6

25.5

669

4365

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.5

25.4

717

4753

R4110, ,

SPAT

1.4

25.4

1050

7525

IAB07

NOMESCO Finland

Consultation concerning a patient with self-harm intention

4.6

25.4

132

IGY99

NOMESCO Finland

Other psychiatric treatment contact

2.1

25.3

250

1222

N03AX11

ATC

topiramate; oral

2.1

25.3

255

1256

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.7

25.3

431

2518

E66.00

ICD-10 Finland

Metabolic syndrome

1.7

25.2

430

2513

H01.0

ICD-10 Finland

Blepharitis

1.6

25.1

647

4201

N02CC04

ATC

rizatriptan; oral

1.6

25.1

547

3411

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

25.1

3410

29084

PA6AD

NOMESCO Finland

CT of neck arteries

2.0

25.1

290

1501

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

25.1

6584

60549

C02AC05

ATC

moxonidine; oral

1.9

25.1

295

1536

R03AK11

ATC

formoterol and fluticasone; inhalant

2.2

25.0

219

1022

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

1.5

25.0

713

4738

K07.60

ICD-10 Finland

Snapping jaw

1.7

25.0

524

3237

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.5

24.9

747

5018

A04AA01

ATC

ondansetron; systemic, rectal

1.6

24.9

657

4290

TPH07

NOMESCO Finland

Cathetrisation of artery

1.5

24.9

765

5166

IGY02

NOMESCO Finland

Psychiatric monitoring contact

1.8

24.9

347

1910

SPAT1252

SPAT

Overall medication plan or its review

1.7

24.9

429

2515

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

2.0

24.8

271

1374

SPAT1312

SPAT

General health counselling

1.3

24.8

2814

23475

J33.8

ICD-10 Finland

Other polyp of sinus

2.5

24.8

160

655

S97

ICPC

Chronic ulcer skin

1.8

24.8

403

2322

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.7

24.7

483

2930

S22.3

ICD-10 Finland

Fracture of rib

1.7

24.5

514

3175

A10BH01

ATC

sitagliptin; oral

1.6

24.3

587

3755

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.4

24.1

1037

7482

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

2.1

24.1

233

1131

SPAT1240

SPAT

Therapeutic discussion

1.4

24.0

1020

7341

WX320

NOMESCO Finland

Spinalanesthesy

1.3

24.0

1859

14736

J01

ICD-10 Finland

Acute sinusitis

1.6

24.0

554

3505

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.7

24.0

481

2938

N05AX12

ATC

aripiprazole; systemic

1.7

23.9

403

2346

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.6

23.9

617

4008

S87

ICPC

Dermatitis/atopic eczema

2.0

23.9

254

1276

EB1VA, ,

NOMESCO Finland

1.3

23.9

1556

12026

K29.7

ICD-10 Finland

Gastritis, unspecified

2.0

23.8

272

1402

H53.2

ICD-10 Finland

Diplopia

2.0

23.8

255

1285

N73.9

ICD-10 Finland

Female pelvic inflammatory disease, unspecified

2.3

23.8

180

792

R06.5

ICD-10 Finland

Mouth breathing

1.5

23.7

699

4678

C10AA05

ATC

atorvastatin; oral

1.3

23.6

2735

22850

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

23.6

3656

31600

E000007, ,

ATC

1.7

23.5

475

2907

F44.9

ICD-10 Finland

Dissociative [conversion] disorder, unspecified

3.5

23.4

221

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

2.0

23.4

269

1390

Y84

ICD-10 Finland

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.3

23.4

260

M54.8

ICD-10 Finland

Other dorsalgia

1.7

23.3

412

2432

205

Kela drug reimbursment

Chronic hypertension

1.4

23.3

1453

11152

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

2.0

23.3

262

1344

S10

ICPC

Boil/carbuncle

1.7

23.2

486

3000

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.0

23.1

261

1340

I47.9

ICD-10 Finland

Paroxysmal tachycardia, unspecified

2.4

23.1

159

671

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.9

23.1

302

1629

XA402

NOMESCO Finland

ENMG

2.1

23.0

207

977

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.5

23.0

888

6278

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

2.3

23.0

170

741

H29

ICPC

Ear symptom/complaint other

1.4

22.9

970

6977

N02AJ13

ATC

tramadol and paracetamol; systemic

2.2

22.8

191

876

NH1BA

NOMESCO Finland

Ankle extensive X-ray examination

2.0

22.8

246

1243

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.2

22.7

200

937

TKC20

NOMESCO Finland

Catheterisation of bladder

1.7

22.7

409

2428

U71

ICPC

Cystitis/urinary infection other

1.6

22.7

614

4033

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

1.8

22.6

329

1834

-1, ,

NOMESCO Finland

1.3

22.6

3077

26167

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

2.4

22.6

160

684

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

1.6

22.6

583

3787

F41.00

ICD-10 Finland

Moderate panic disorder

2.3

22.5

177

791

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.7

22.5

466

2868

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

1.7

22.5

383

2236

WX722

NOMESCO Finland

PEEP

1.9

22.5

305

1664

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.0

22.5

230

1140

R4140

NOMESCO Finland

Psychotherapy

3.4

22.5

232

DNB20

NOMESCO Finland

Endoscopic ethmoidectomy

2.1

22.5

225

1107

KMAK, ,

NOMESCO Finland

1.2

22.3

4577

40696

F31.8

ICD-10 Finland

Other bipolar affective disorders

2.2

22.3

194

904

GD1AD

NOMESCO Finland

Thorax CT examination

1.7

22.2

435

2640

E66.9

ICD-10 Finland

Obesity, unspecified

1.8

22.2

341

1934

R75

ICPC

Sinusitis acute/chronic

1.7

22.2

456

2803

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.5

22.1

791

5508

A13

ICPC

Concern/fear medical treatment

2.3

22.1

172

766

R5110, ,

SPAT

1.6

22.1

601

3951

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

2.1

22.1

198

934

R60.1

ICD-10 Finland

Generalized oedema

3.4

22.0

240

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

1.7

22.0

434

2639

D19

ICPC

Teeth/gum symptom/complaint

1.3

22.0

2892

24481

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

1.7

22.0

420

2533

J39.3

ICD-10 Finland

Upper respiratory tract hypersensitivity reaction, site unspecified

5.3

22.0

SPAT1058

SPAT

PEF monitoring instruction

1.6

21.9

604

3981

ZX114

NOMESCO Finland

Intramuscular

2.5

21.9

132

524

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.4

21.9

860

6097

I50.9

ICD-10 Finland

Heart failure, unspecified

1.5

21.9

686

4650

S43.4

ICD-10 Finland

Sprain and strain of shoulder joint

1.8

21.9

337

1913

TAB00

NOMESCO Finland

Lumbar puncture

1.7

21.8

385

2271

ZX112

NOMESCO Finland

Subcutaneous

2.3

21.8

169

751

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

1.9

21.8

284

1530

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

2.0

21.7

242

1237

K07.63

ICD-10 Finland

Pain in the jaw joint UNS

2.1

21.7

198

940

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.5

21.7

639

4275

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

3.8

21.7

176

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.0

21.7

225

1122

J37.0

ICD-10 Finland

Chronic laryngitis

1.9

21.6

264

1392

WYA10

NOMESCO Finland

Emergency care or similar visit

1.5

21.6

660

4448

A85

ICPC

Adverse effect medical agent

2.8

21.6

105

374

WVA40

NOMESCO Finland

Initiation and monitoring of intravenous hydration

2.7

21.5

112

413

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

1.4

21.5

903

6480

SGC00

NOMESCO Finland

Medication, disinfection of root canals

1.4

21.5

910

6540

V01AA02

ATC

grass pollen; parenteral

4.1

21.5

146

M48.0

ICD-10 Finland

Spinal stenosis

1.5

21.5

738

5098

SGA03

NOMESCO Finland

Opening and preparing the root canals, complicated

1.5

21.5

826

5833

C08CA05

ATC

nifedipine; systemic

1.7

21.4

384

2275

ZXX03

NOMESCO Finland

Extent of procedure, 3 units

3.7

21.4

182

N03AF01

ATC

carbamazepine; oral, rectal

1.8

21.4

340

1948

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

2.1

21.4

201

966

IAB01

NOMESCO Finland

Psychiatric pharmacotherapy consultation

2.8

21.4

107

387

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.4

21.3

890

6379

L02.9

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle, unspecified

1.8

21.3

293

1607

R52.0

ICD-10 Finland

Acute pain

1.8

21.2

303

1680

G50.1

ICD-10 Finland

Atypical facial pain

2.3

21.2

162

716

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.4

21.2

858

6117

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

1.7

21.2

380

2253

F44.7

ICD-10 Finland

Mixed dissociative [conversion] disorders

7.2

21.2

F01

ICPC

Eye pain

1.9

21.1

281

1524

E87.6

ICD-10 Finland

Hypokalaemia

1.9

21.1

247

1284

O99.5

ICD-10 Finland

Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium

3.0

21.1

308

R06AX12

ATC

terfenadine; oral

1.7

21.1

372

2195

SPAT1262

SPAT

Handing over of treatment supplies

1.4

21.1

1145

8590

SGA02

NOMESCO Finland

Opening and preparing the root canals

1.4

21.1

1035

7636

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

1.7

21.0

377

2235

J32.4

ICD-10 Finland

Chronic pansinusitis

2.4

21.0

142

595

W80

ICD-10 Finland

Inhalation and ingestion of other objects causing obstruction of respiratory tract

8.5

21.0

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.5

20.9

646

4364

S83.4

ICD-10 Finland

Sprain and strain involving (fibular)(tibial) collateral ligament of knee

1.8

20.9

305

1703

R30.0

ICD-10 Finland

Dysuria

1.7

20.9

389

2329

C01DA14

ATC

isosorbide mononitrate; oral

1.5

20.9

736

5108

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.3

20.9

2288

18930

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

1.7

20.9

372

2201

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

2.0

20.9

216

1076

L86

ICPC

Back syndrome with radiating pain

1.6

20.8

500

3193

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

2.1

20.8

203

990

A02BA04

ATC

nizatidine; systemic

1.6

20.7

459

2874

RD210, ,

NOMESCO Finland

2.2

20.7

173

794

I49.3

ICD-10 Finland

Ventricular premature depolarization

1.6

20.6

539

3511

C03AA03

ATC

hydrochlorothiazide; oral

1.6

20.6

521

3368

D07BC01

ATC

betamethasone and antiseptics; topical

1.4

20.6

858

6147

Z71.9

ICD-10 Finland

Counselling, unspecified

1.5

20.6

689

4733

S90.3

ICD-10 Finland

Contusion of other and unspecified parts of foot

1.9

20.6

260

1388

S14

ICPC

Burn/scald

1.8

20.6

308

1734

IDY03

NOMESCO Finland

Systematic individual therapy, cognitive-behavioural

1.6

20.5

432

2671

H10.9

ICD-10 Finland

Conjunctivitis, unspecified

1.5

20.5

669

4572

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.5

20.5

772

5428

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.4

20.5

1083

8085

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

1.8

20.5

309

1743

K29.1

ICD-10 Finland

Other acute gastritis

2.7

20.5

107

396

SPAT1212

SPAT

Extensive examination of musculoskeletal system

1.5

20.5

601

4018

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.4

20.3

797

5646

R10.2

ICD-10 Finland

Pelvic and perineal pain

2.0

20.3

228

1169

NG4AA

NOMESCO Finland

Lower leg X-ray examination

1.9

20.3

264

1422

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

3.2

20.3

253

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

3.9

20.2

153

S06

ICPC

Rash localized

1.6

20.2

441

2753

K08.3

ICD-10 Finland

Retained dental root

1.6

20.2

538

3521

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.8

20.1

297

1664

J39.9

ICD-10 Finland

Disease of upper respiratory tract, unspecified

3.2

20.1

239

SPAT1216

SPAT

Assessment of functional ability

1.4

20.1

968

7115

C10AC01

ATC

colestyramine; oral

2.0

20.1

227

1167

ZXD35

NOMESCO Finland

Usual procedure

1.9

20.1

233

1209

K03.80

ICD-10 Finland

Irradiated enamel

1.6

20.1

520

3381

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

2.1

20.0

181

857

XQ848

NOMESCO Finland

Dermatological photography

2.0

19.9

224

1149

S80.1

ICD-10 Finland

Contusion of other and unspecified parts of lower leg

1.8

19.9

282

1560

F90.0

ICD-10 Finland

Disturbance of activity and attention

1.6

19.9

452

2848

LCA06

NOMESCO Finland

Biopsy of endometrium

1.4

19.9

979

7220

3023

Kela drug reimbursment

Allergen extract of birch pollen (adults)

4.0

19.9

137

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.7

19.9

408

2507

S63.6

ICD-10 Finland

Sprain and strain of finger(s)

1.7

19.9

378

2277

SPAT1097

SPAT

Recording of ECG

1.4

19.8

922

6735

N06AX03

ATC

mianserin; oral

1.7

19.8

330

1916

SPAT1281

SPAT

Other administrative function

1.5

19.8

615

4159

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.4

19.8

822

5885

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

2.0

19.8

222

1139

H81.3

ICD-10 Finland

Other peripheral vertigo

2.0

19.7

215

1091

UJH02

NOMESCO Finland

Anoscopy

1.8

19.7

299

1689

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.4

19.7

922

6741

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

1.7

19.7

357

2123

Y97

ICD-10 Finland

Environmental-pollution-related condition

73.6

19.7

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.4

19.7

994

7365

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

1.9

19.6

240

1268

J01CF05

ATC

flucloxacillin; systemic

1.5

19.6

581

3892

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.4

19.6

1090

8203

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

1.8

19.6

312

1789

N80.9

ICD-10 Finland

Endometriosis, unspecified

2.0

19.6

218

1115

JN4BD

NOMESCO Finland

Extensive body CT

1.5

19.6

639

4368

B34.9

ICD-10 Finland

Viral infection, unspecified

1.8

19.5

294

1658

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

1.8

19.5

292

1645

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

1.9

19.5

235

1236

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.8

19.4

316

1824

S92.5

ICD-10 Finland

Fracture of other toe

1.9

19.3

261

1423

K59.0

ICD-10 Finland

Constipation

1.6

19.3

419

2610

N92.6

ICD-10 Finland

Irregular menstruation, unspecified

1.5

19.3

659

4545

K13.79

ICD-10 Finland

Change in the oral mucosa UNS

1.9

19.1

249

1342

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.5

19.1

710

4978

N05AH03

ATC

olanzapine; systemic

1.6

19.1

511

3348

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

2.0

19.1

200

1002

W52

ICD-10 Finland

Crushed, pushed or stepped on by crowd or human stampede

2.2

19.0

152

685

F61.0

ICD-10 Finland

Mixed personality disorders

2.2

19.0

160

737

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.5

19.0

718

5050

UJF92

NOMESCO Finland

Capsular endoscopy

2.1

18.9

189

930

R03DC01

ATC

zafirlukast; oral

2.5

18.9

120

489

K04.1

ICD-10 Finland

Necrosis of pulp

1.4

18.9

899

6593

B02.9

ICD-10 Finland

Zoster without complication

1.6

18.8

488

3173

XG405

NOMESCO Finland

Education on PEF monitoring

2.4

18.8

123

508

F10.09

ICD-10 Finland

Alcohol intoxication UNS

2.2

18.8

157

721

3007

Kela drug reimbursment

Erenumab and fremanezumab

2.2

18.8

152

689

W10

ICD-10 Finland

Fall on and from stairs and steps

1.6

18.7

401

2491

NH1BG

NOMESCO Finland

Ankle and foot MRI examination with high intensity magnet

2.0

18.7

203

1029

G81.9

ICD-10 Finland

Hemiplegia, unspecified

2.9

18.7

308

M03BX01

ATC

baclofen; systemic

2.2

18.7

158

729

C10AA01

ATC

simvastatin; oral

1.3

18.7

2350

19718

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.5

18.7

710

5000

R07

ICPC

Sneezing/nasal congestion

1.5

18.6

648

4485

XQ818

NOMESCO Finland

Conjunctival allergen provocation test

7.0

18.6

XQ810

NOMESCO Finland

Physical test for urticaria

7.3

18.6

SPAT1301

SPAT

No procedures

1.2

18.6

2441

20576

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.6

18.6

425

2682

P01BA02

ATC

hydroxychloroquine; oral

1.5

18.6

628

4323

Z04.4

ICD-10 Finland

Examination and observation following alleged rape and seduction

3.1

18.5

246

R81

ICPC

Pneumonia

1.8

18.5

286

1625

F43.20

ICD-10 Finland

Adaptation disorder with short-term depression

2.3

18.5

135

586

N06AX22

ATC

agomelatine; oral

1.9

18.5

224

1180

K29.3

ICD-10 Finland

Chronic superficial gastritis

2.0

18.4

210

1083

M54.0

ICD-10 Finland

Panniculitis affecting regions of neck and back

2.4

18.4

123

513

R31

ICD-10 Finland

Unspecified haematuria

1.5

18.4

580

3934

A27

ICPC

Fear of other disease NOS

1.6

18.4

388

2401

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

1.9

18.4

230

1224

TPX10

NOMESCO Finland

Implantation of vascular injection port

1.9

18.4

220

1154

J34.2

ICD-10 Finland

Deviated nasal septum

1.7

18.4

376

2309

L27.1

ICD-10 Finland

Localized skin eruption due to drugs and medicaments

3.5

18.4

173

UDC00

NOMESCO Finland

Ear microscopy

1.5

18.3

565

3815

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.4

18.3

806

5829

K85

ICPC

Elevated blood pressure

1.4

18.3

1101

8383

1220

FHL

Arthroscopy

1.8

18.3

258

1427

R68.88

ICD-10 Finland

Other specified general symptoms and signs, not elsewhere classified.

2.7

18.3

351

J01DA08

ATC

[U] cefaclor

1.4

18.3

1070

8114

Q79.6

ICD-10 Finland

Ehlers-Danlos syndrome

4.0

18.2

124

N03AF02

ATC

oxcarbazepine; oral

1.8

18.2

262

1458

I49.8

ICD-10 Finland

Other specified cardiac arrhythmias

1.8

18.2

249

1364

M75.8

ICD-10 Finland

Other shoulder lesions

1.7

18.2

331

1971

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

2.5

18.2

117

480

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.6

18.2

415

2619

R23.3

ICD-10 Finland

Spontaneous ecchymoses

2.1

18.2

171

823

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

1.8

18.2

255

1408

R03BB01

ATC

ipratropium bromide; inhalant

2.0

18.1

204

1048

S50.0

ICD-10 Finland

Contusion of elbow

1.8

18.1

276

1563

F60.9

ICD-10 Finland

Personality disorder, unspecified

2.4

18.1

126

536

SXA20

NOMESCO Finland

Local application of medicine to mouth

1.5

18.1

546

3672

R04

ICPC

Breathing problem other

1.7

18.1

305

1779

H57.9

ICD-10 Finland

Disorder of eye and adnexa, unspecified

2.5

18.0

108

429

L53.9

ICD-10 Finland

Erythematous condition, unspecified

2.5

18.0

111

447

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

2.1

17.9

169

814

F32.1

ICD-10 Finland

Moderate depressive episode

1.5

17.9

598

4104

N06AB05

ATC

paroxetine; oral

1.6

17.9

465

3024

ZXD20

NOMESCO Finland

Day surgery

1.4

17.9

945

7047

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.4

17.9

1061

8061

R35

ICD-10 Finland

Polyuria

1.6

17.9

439

2820

SPAT1267

SPAT

Desensitisation

5.5

17.9

N64.4

ICD-10 Finland

Mastodynia

1.7

17.8

340

2050

M77.4

ICD-10 Finland

Metatarsalgia

1.5

17.8

523

3497

H10

ICD-10 Finland

Conjunctivitis

1.4

17.8

700

4962

B01AF02

ATC

apixaban; oral

1.4

17.8

748

5367

F03

ICPC

Eye discharge

1.5

17.7

610

4213

G83.4

ICD-10 Finland

Cauda equina syndrome

3.9

17.7

131

UJD02

NOMESCO Finland

Gastroscopy

1.7

17.7

320

1903

F43.0

ICD-10 Finland

Acute stress reaction

1.5

17.6

584

4004

S20.2

ICD-10 Finland

Contusion of thorax

1.6

17.6

386

2413

XG404

NOMESCO Finland

Peak expiratory flow (PEF) measurement

2.9

17.6

270

-60

ICPC

Result test/procedure

1.6

17.5

412

2619

B01AB04

ATC

dalteparin; parenteral

1.7

17.4

357

2194

4930B

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA CUM EXACERBATIONE]

3.3

17.4

194

ICB06, ,

NOMESCO Finland

2.6

17.4

372

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.4

17.3

743

5349

Y04.0

ICD-10 Finland

Assault by bodily force by spouse or partner

3.8

17.3

138

SPAT1153

SPAT

Removal of sutures

1.2

17.2

2219

18641

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

1.8

17.2

271

1551

M23.8

ICD-10 Finland

Other internal derangements of knee

1.7

17.2

314

1873

S90.0

ICD-10 Finland

Contusion of ankle

2.0

17.2

190

971

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

1.6

17.2

376

2350

A10BK01

ATC

dapagliflozin; oral

1.5

17.1

497

3313

SPAT1307

SPAT

Psychosocial counselling and guidance

1.5

17.1

623

4349

EN1AD

NOMESCO Finland

CT examination of mouth and soft tissues of neck

2.5

17.1

103

410

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.2

17.1

3132

27299

ZXY01

NOMESCO Finland

Chief Physician, Head of Department or Deputy Chief Physician

2.9

17.0

264

A03CA02

ATC

clidinium and psycholeptics; oral

1.7

17.0

339

2068

R01AD59

ATC

mometasone, combinations; nasal

1.5

17.0

640

4497

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.5

17.0

538

3653

B01AB10

ATC

tinzaparin; parenteral

1.4

17.0

790

5768

L23.5

ICD-10 Finland

Allergic contact dermatitis due to other chemical products

2.7

17.0

325

Z91.0

ICD-10 Finland

Personal history of allergy, other than to drugs and biological substances

15.9

17.0

L18

ICPC

Muscle pain

1.6

16.9

356

2202

SGC10

NOMESCO Finland

Pulp capping

1.4

16.9

776

5651

E66

ICD-10 Finland

Obesity

1.5

16.9

502

3364

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

2.6

16.9

383

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

1.7

16.9

298

1760

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

1.9

16.9

218

1174

R49.08

ICD-10 Finland

Other specified dysphonia

2.0

16.8

179

903

ZXE17

NOMESCO Finland

Procedure duration 150 to 179 minutes

2.5

16.8

101

402

S70.0

ICD-10 Finland

Contusion of hip

1.8

16.8

271

1562

F41.0

ICD-10 Finland

Panic disorder [episodic paroxysmal anxiety]

1.8

16.8

252

1422

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

2.0

16.7

177

890

L88

ICPC

Rheumatoid/seropositive arthritis

1.7

16.7

318

1917

S61.0

ICD-10 Finland

Open wound of finger(s) without damage to nail

1.4

16.7

727

5246

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

1.9

16.7

224

1221

H70

ICPC

Otitis externa

2.0

16.7

182

926

I50.0

ICD-10 Finland

Congestive heart failure

1.7

16.7

339

2080

G56.2

ICD-10 Finland

Lesion of ulnar nerve

1.8

16.6

252

1425

L05

ICPC

Flank/axilla symptom/complaint

1.5

16.6

489

3271

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.6

16.6

385

2440

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

2.5

16.6

103

416

G04CA02

ATC

tamsulosin; oral

1.3

16.6

1050

8052

R07.1

ICD-10 Finland

Chest pain on breathing

2.2

16.5

137

628

R09.1

ICD-10 Finland

Pleurisy

2.1

16.5

152

726

N06AA10

ATC

nortriptyline; systemic

2.1

16.5

163

800

SGB10

NOMESCO Finland

Root filling of tooth with one root canal

1.4

16.5

920

6919

DFF00

NOMESCO Finland

Pure tone audiometry

1.4

16.5

686

4911

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

1.7

16.5

323

1963

-69

ICPC

Other reason for encounter NEC

1.7

16.4

269

1556

F41.8

ICD-10 Finland

Other specified anxiety disorders

1.7

16.4

336

2064

K92.0

ICD-10 Finland

Haematemesis

2.1

16.4

149

708

R2110

NOMESCO Finland

Giving the first information

1.5

16.4

551

3787

K11.2

ICD-10 Finland

Sialoadenitis

1.7

16.4

273

1587

S16

ICPC

Bruise/contusion

1.8

16.4

230

1271

NG1BA, ,

SPAT

2.0

16.4

174

877

D09AB01

ATC

zinc bandage without supplements; topical

2.2

16.3

142

664

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.6

16.3

436

2857

7080A

ICD-9 Finland

Urticaria, Allergic urticaria

5.2

16.2

R01

ICPC

Pain respiratory system

2.1

16.2

150

718

XCK10

NOMESCO Finland

Photography of fundus of eye

1.5

16.2

578

4020

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

2.2

16.2

138

640

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

2.0

16.2

163

806

L20.8

ICD-10 Finland

Other atopic dermatitis

2.3

16.2

118

513

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.6

16.2

343

2127

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.2

16.1

4884

44516

J01CA08

ATC

pivmecillinam; oral

1.2

16.1

3705

32944

N05AE04

ATC

ziprasidone; systemic

3.0

16.1

235

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.2

16.1

2368

20158

A10BK03

ATC

empagliflozin; oral

1.4

16.1

631

4469

J33.0

ICD-10 Finland

Polyp of nasal cavity

1.9

16.0

202

1079

A10BH05

ATC

linagliptin; oral

1.7

16.0

278

1636

N06AX05

ATC

trazodone; oral

1.9

16.0

202

1080

R03AK03

ATC

[U] fenoterol and ipratropium bromide

1.8

16.0

251

1435

NB2AT

NOMESCO Finland

Intra artrial injection of shoulder with ultrasound guidance

2.4

15.9

110

467

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

1.6

15.9

404

2617

L60.0

ICD-10 Finland

Ingrowing nail

1.6

15.9

390

2506

L01BA01

ATC

methotrexate; systemic

1.7

15.8

263

1528

PD5AD

NOMESCO Finland

CT of aorta

2.1

15.8

150

725

L04AD01

ATC

ciclosporin; systemic

2.1

15.8

151

732

J38.4

ICD-10 Finland

Oedema of larynx

3.6

15.8

147

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.4

15.8

635

4519

NF1AA

NOMESCO Finland

Hip X-ray examination

1.5

15.7

558

3877

C08CA02

ATC

felodipine; oral

1.5

15.7

508

3466

XX9AW

NOMESCO Finland

Production of copy from X-ray picture

1.7

15.7

268

1570

EBA10

NOMESCO Finland

Operative extraction of tooth

1.3

15.7

1281

10175

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

2.0

15.7

178

919

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

1.7

15.6

262

1526

D11AX15

ATC

[U] pimecrolimus

4.3

15.6

A10BJ06

ATC

semaglutide; parenteral

1.6

15.6

368

2342

D06BB03

ATC

aciclovir; topical

1.6

15.5

347

2180

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

2.1

15.5

149

724

ZXY51

NOMESCO Finland

2-person team, doctor-nurse

2.1

15.5

149

724

M01AC06

ATC

meloxicam; systemic, rectal

1.2

15.5

2663

23009

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.4

15.5

587

4129

DHB50

NOMESCO Finland

Turbinoplasty

1.9

15.5

202

1091

R04.2

ICD-10 Finland

Haemoptysis

1.9

15.5

199

1070

G50.0

ICD-10 Finland

Trigeminal neuralgia

2.1

15.5

145

698

L30.4

ICD-10 Finland

Erythema intertrigo

2.3

15.4

116

511

B03BA03

ATC

hydroxocobalamin; parenteral

1.6

15.4

327

2028

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

2.2

15.4

121

543

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

1.5

15.4

555

3868

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

2.2

15.4

130

601

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.6

15.4

320

1975

L10

ICPC

Elbow symptom/complaint

1.5

15.4

457

3064

R25.1

ICD-10 Finland

Tremor, unspecified

1.8

15.3

212

1167

A10BJ02

ATC

liraglutide; parenteral

1.8

15.3

209

1146

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

1.8

15.3

209

1146

ZXX04

NOMESCO Finland

Extent of procedure, 4 units

3.6

15.3

136

L09

ICPC

Arm symptom/complaint

1.5

15.3

419

2760

G40.9

ICD-10 Finland

Epilepsy, unspecified

1.8

15.3

235

1336

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

1.7

15.3

286

1718

D64.9

ICD-10 Finland

Anaemia, unspecified

1.4

15.3

644

4621

Y04.8

ICD-10 Finland

Assault by bodily force by other known person

3.3

15.2

170

TLC00

NOMESCO Finland

Insertion of intrauterine device

1.4

15.2

604

4287

D12

ICPC

Constipation

1.7

15.2

262

1539

U13

ICPC

Bladder symptom/complaint other

1.8

15.2

213

1178

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.5

15.2

448

2999

I20.00

ICD-10 Finland

Unstable angina

2.1

15.2

141

677

TQW40

NOMESCO Finland

Remowal of suture of skin

1.5

15.1

492

3360

N63

ICD-10 Finland

Unspecified lump in breast

1.4

15.1

603

4284

D84.1

ICD-10 Finland

Defects in the complement system

20.0

15.1

B37.3

ICD-10 Finland

Candidiasis of vulva and vagina

1.9

15.0

175

911

J01MA01

ATC

ofloxacin; systemic

1.5

15.0

493

3374

J02AC02

ATC

itraconazole; systemic

1.3

15.0

1320

10583

P02

ICPC

Acute stress reaction

1.4

15.0

563

3955

49300

ICD-8 Finland

Asthma, bronchiale

2.0

15.0

153

761

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.3

14.9

1640

13504

J01AA04

ATC

lymecycline; systemic

1.3

14.9

1140

8970

J38.5

ICD-10 Finland

Laryngeal spasm

4.4

14.9

R5599

NOMESCO Finland

Other rehabilitation service

1.8

14.9

211

1170

D07AC14

ATC

methylprednisolone aceponate; topical

1.6

14.9

336

2116

P25

ICPC

Phase of life problem adult

1.5

14.9

419

2777

TEW99

NOMESCO Finland

Other minor procedure in surgery of teeth, jaws, mouth and pharynx

1.6

14.9

365

2346

ZY000

NOMESCO Finland

Hospital inpatient

2.2

14.9

122

558

N02CC07

ATC

frovatriptan; oral

1.6

14.9

390

2545

JN4AD

NOMESCO Finland

Body CT examination

1.4

14.9

710

5206

N06BA04

ATC

methylphenidate; oral

1.6

14.8

381

2474

XKD00

NOMESCO Finland

Uroflowmetry

1.4

14.8

762

5654

N05CD07

ATC

temazepam; oral

1.4

14.8

627

4502

NK4AT

NOMESCO Finland

Puncture of joint with ultrasound guidance not elsewher classified

2.7

14.8

291

S01GX04

ATC

nedocromil; ophthalmic

2.1

14.7

135

645

F43.01

ICD-10 Finland

Acute stress reaction moderate

2.0

14.7

167

862

K07.68

ICD-10 Finland

Other disorders of the jaw joint

2.6

14.7

338

L84

ICPC

Back syndrome without radiat pain

1.6

14.7

382

2487

D07XC01

ATC

betamethasone; topical

1.4

14.7

815

6122

R01BA51

ATC

phenylpropanolamine, combinations; oral

1.3

14.7

1056

8241

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

1.7

14.7

260

1539

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.5

14.7

467

3176

C05AA08

ATC

fluocortolone; rectal, topical

1.3

14.7

917

7014

NG1CG

NOMESCO Finland

Knee and lower leg extensive MRI examination with high intensity magnet

1.9

14.7

195

1061

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

2.0

14.7

154

774

N05BA06

ATC

lorazepam; systemic, sublingual

1.6

14.6

317

1977

F32

ICD-10 Finland

Depressive episode

1.5

14.6

496

3416

L99

ICPC

Musculoskeletal disease other

1.9

14.6

178

941

D03

ICPC

Heartburn

1.6

14.6

310

1924

B06AC05

ATC

lanadelumab; parenteral

+∞

14.6

L02

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle

1.6

14.6

318

1987

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.0

14.6

159

810

J03

ICD-10 Finland

Acute tonsillitis

1.7

14.5

279

1687

R04.0

ICD-10 Finland

Epistaxis

1.5

14.5

460

3124

L50.2

ICD-10 Finland

Urticaria due to cold and heat

4.0

14.5

104

XJC02

NOMESCO Finland

Mesurement of oesophageal pressure and pressure profile of lower oesophageal sphincter

3.8

14.5

113

K07.61

ICD-10 Finland

Cracking jaw joint

1.8

14.5

202

1115

KCV04

NOMESCO Finland

Distension of bladder with fluid

2.8

14.5

255

K35.9

ICD-10 Finland

Acute appendicitis, unspecified

1.4

14.5

590

4207

NH1CG

NOMESCO Finland

Ankle and foot extensive MRI examination with high intensity magnet

2.2

14.4

123

571

L01.1

ICD-10 Finland

Impetiginization of other dermatoses

2.9

14.4

223

EMB10

NOMESCO Finland

Tonsillectomy

1.4

14.4

548

3858

Z72.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

370

53.36

307.65

1.1

1.0

0.39

0.03

u/ml

1.74

223

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

1230

2920

4.67

307.65

1.7

1.8

1.21

1.18

g/l

1.93

1137

2805

(3019420) Tryptase [Mass/volume] in Serum or Plasma

927

447

22.80

307.65

1.5

8.50

7.39

ug/l

0.44

813

415

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

749

255

31.72

307.65

1.3

1.2

0.31

0.29

g/l

1.90

584

209

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

1232

2829

4.84

307.65

1.8

1.9

0.24

0.23

g/l

1.81

1132

2711

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

731

231

34.11

307.65

1.3

1.2

110.89

110.09

0.17

673

206

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

231

26.86

307.65

1.0

0.32

0.03

u/ml

2.14

141

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

359

209

17.79

307.65

1.2

10.53

8.99

u/ml

0.12

259

138

(3005322) IgE [Units/volume] in Serum or Plasma

2096

6630

3.75

307.65

1.6

1.3

418.92

212.38

u/ml

4.06

2016

6159

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

227

113

20.54

298.21

1.1

3.96

4.84

u/ml

0.15

178

(3012494) Peanut IgE Ab [Units/volume] in Serum

313

307

10.50

281.26

1.1

16.13

13.04

u/ml

0.10

232

179

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

218

114

19.53

280.18

1.1

1.0

5.05

0.43

u/ml

0.98

118

(3011841) English Walnut IgE Ab [Units/volume] in Serum

215

112

19.60

276.79

1.1

5.59

4.94

u/ml

0.09

169

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

212

110

19.68

273.40

1.1

1.0

0.71

0.16

u/ml

1.15

115

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

202

102

20.20

263.62

1.1

1.0

1.76

0.12

u/ml

1.09

110

(3022096) Basophils/Leukocytes in Blood

5906

41217

2.09

262.14

7.8

6.9

0.66

0.68

2.23

5621

38741

(3006504) Eosinophils/Leukocytes in Blood

5901

41255

2.08

259.54

7.8

6.8

2.95

2.82

3.71

5622

38841

(3019069) Monocytes/Leukocytes in Blood

5908

41328

2.08

259.35

7.8

6.9

8.35

8.60

10.34

5644

38943

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

194

19.97

251.97

1.1

1.0

1.18

2.07

u/ml

0.36

136

(3013115) Eosinophils [#/volume] in Blood

6413

46559

2.09

250.35

7.9

6.8

0.20

0.19

e9/l

8.80

5714

41054

(3002030) Lymphocytes/Leukocytes in Blood

6009

42610

2.06

250.07

7.8

6.7

28.44

28.94

3.25

5786

40551

(3006315) Basophils [#/volume] in Blood

6260

45103

2.07

248.72

7.6

6.6

0.04

e9/l

0.70

5478

39091

(3001604) Monocytes [#/volume] in Blood

6250

45017

2.07

248.37

7.6

6.6

0.57

0.56

e9/l

0.53

5477

39042

(3018010) Neutrophils/Leukocytes in Blood

5922

41894

2.05

246.48

7.6

6.6

56.96

56.52

2.29

5723

40176

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

159

31.67

245.24

1.1

1.0

1.81

0.14

u/ml

0.95

150

(3019198) Lymphocytes [#/volume] in Blood

6344

46165

2.06

242.11

7.7

6.6

1.97

1.96

e9/l

0.35

5700

41000

(3013650) Neutrophils [#/volume] in Blood by Automated count

6707

50120

2.07

233.69

10.6

9.7

4.21

4.01

e9/l

8.58

5879

43621

(3016031) Almond IgE Ab [Units/volume] in Serum

165

22.97

227.41

1.1

0.84

1.65

u/ml

0.59

(3027231) Wheat IgE Ab [Units/volume] in Serum

234

223

10.72

214.32

1.2

1.1

9.98

2.52

u/ml

0.91

195

204

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

153

23.18

211.68

1.0

2.80

2.01

u/ml

0.15

124

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

3233

19582

1.97

197.58

2.1

1.9

0.93

1.13

mg/l

3.78

2451

14903

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

152

19.53

195.68

1.1

0.34

0.25

u/ml

0.15

152

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

385

723

5.50

194.49

1.3

3.71

2.65

u/ml

0.78

307

403

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

5787

43027

1.84

180.54

7.1

6.4

10.45

11.11

umol/l

3.79

5551

40922

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

125

23.87

175.01

1.1

1.0

16.34

17.44

u/ml

0.06

(3013826) Glucose [Moles/volume] in Serum or Plasma

6303

48525

1.84

171.00

6.4

4.9

6.53

6.51

mmol/l

0.31

6045

45261

(3021589) Normoblasts [#/volume] in Blood

5352

39272

1.80

169.97

13.1

10.9

0.00

e9/l

1.65

4388

32000

(3003888) Timothy IgE Ab [Units/volume] in Serum

716

2357

3.20

168.93

1.2

1.1

4.68

5.47

u/ml

0.74

509

1307

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

774

2698

3.03

165.44

1.2

1.1

2.46

2.11

u/ml

0.43

546

1452

(3002582) Erythrocytes [#/volume] in Urine

3927

26620

1.79

160.10

4.1

3.3

54.16

69.19

e6/l

0.29

3079

19970

(36304419) Bacteria [Presence] in Urine

3411

22203

1.82

159.01

4.0

3.1

255.26

173.23

estimate

—

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

129

17.65

158.55

1.5

1.4

12.30

1.08

u/ml

1.50

115

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

7663

63458

1.95

157.16

5.4

4.3

11.67

10.77

mm/h

7.21

7287

59896

(3032080) INR in Blood by Coagulation assay

4778

34419

1.76

156.78

13.0

11.9

1.16

1.19

inr

5.04

4025

28578

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

38.77

156.74

1.1

1.40

0.62

u/ml

0.38

(3010726) Horse dander IgE Ab [Units/volume] in Serum

680

2269

3.15

156.55

1.2

1.1

2.94

1.81

u/ml

1.90

474

1183

(3030467) Casts [#/volume] in Urine by Automated count

3504

23078

1.81

156.50

4.1

3.1

0.30

0.37

e6/l

1.70

2641

16601

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

5388

40191

1.76

156.06

8.6

7.1

1.21

1.22

mmol/l

0.37

4764

34887

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

287

504

5.84

155.60

1.8

4.73

2.10

u/ml

0.64

153

(3023368) Bacteria identified in Blood by Culture

3199

20599

1.82

153.28

5.2

4.2

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

3573

23830

1.79

151.82

2.6

2.2

161.32

201.17

u/l

1.27

3412

22630

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

4178

29166

1.75

151.39

4.2

3.3

2.06

1.96

e6/l

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

669

2264

3.10

150.21

1.2

1.1

1.21

1.04

u/ml

0.31

453

1022

(3018095) Leukocytes [#/volume] in Urine

4445

31728

1.73

147.59

5.1

3.8

92.50

84.90

e6/l

0.16

3241

21484

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

7630

63577

1.91

146.87

10.0

8.0

77.24

77.52

u/l

0.21

7342

60557

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

4883

35828

1.72

146.26

8.0

6.6

1.21

mmol/l

0.87

4586

33315

(3033658) Prothrombin time (PT) actual/Normal

3213

21178

1.77

139.35

5.0

4.2

93.31

92.57

0.98

3139

20679

(3026782) Osmolality of Urine

2497

15439

1.83

133.24

3.4

2.8

522.96

527.43

mosm/kgh2o

0.42

2238

13493

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

122

14.02

132.95

1.1

1.0

7.25

8.21

u/ml

0.14

(3037467) Urinalysis macro (dipstick) panel - Urine

7177

59414

1.78

131.64

5.8

4.4

2.19

10.14

0.53

(3037522) Nuclear Ab [Titer] in Serum

2240

13484

1.86

129.83

1.5

1.4

544.30

534.83

titre

0.07

433

2846

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

4016

28605

1.68

128.78

4.5

3.3

25.55

65.81

ng/l

1.47

2429

17252

(3036312) Salmon IgE Ab [Units/volume] in Serum

102

18.39

127.92

1.1

1.0

2.73

0.27

u/ml

1.23

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

2352

14505

1.82

125.39

4.6

3.6

428.94

466.78

ng/l

0.05

1566

10040

(3031040) Bacteria [#/volume] in Urine by Automated count

6905

56940

1.72

123.71

6.1

4.4

401.56

1685.15

e6/l

4.31

680

(3000850) Epithelial cells [#/volume] in Urine

2781

18171

1.74

120.83

3.2

2.7

6.89

6.54

e6/l

0.55

2553

16464

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

3740

26470

1.67

120.63

3.3

2.6

55.60

62.22

u/l

1.41

3485

24646

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2110

12735

1.84

119.99

2.3

1.9

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

2157

13173

1.82

117.72

3.5

3.0

3.96

3.27

e6/l

1.63

1060

6228

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1506

8193

1.99

117.27

2.8

2.5

34.29

43.30

u/l

0.85

1278

6934

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

109

13.60

116.74

1.1

0.06

0.03

u/ml

2.05

109

(3015076) Soybean IgE Ab [Units/volume] in Serum

301

706

4.37

116.44

1.2

1.1

1.85

0.94

u/ml

0.47

178

186

(3024561) Albumin [Mass/volume] in Serum or Plasma

4745

36106

1.61

111.47

5.8

5.1

36.30

36.33

g/l

0.11

4502

33959

(40758558) Short blood count panel - Blood

3637

25970

1.64

110.67

7.0

6.4

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

9282

85246

2.70

108.64

22.6

14.1

19.96

22.04

mg/l

9.94

8179

69119

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

2265

14364

1.75

107.29

3.4

2.8

1.32

1.11

e6/l

0.34

1184

7455

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4017

29567

1.61

106.89

3.4

3.3

31.22

33.14

u/l

0.67

3791

28036

(3020874) Milk IgE Ab [Units/volume] in Serum

312

812

3.94

104.92

1.3

1.1

8.81

0.94

u/ml

2.18

212

287

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

4622

35296

1.59

104.40

2.3

2.0

95.59

97.27

pmol/l

1.71

2604

18909

(3014599) Egg white IgE Ab [Units/volume] in Serum

304

785

3.96

103.35

1.3

1.1

15.62

1.48

u/ml

1.51

189

217

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1942

11942

1.78

101.65

2.3

2.4

29.60

29.45

0.50

1892

11602

(3014133) Dog dander IgE Ab [Units/volume] in Serum

535

1982

2.80

101.29

1.1

6.28

4.39

u/ml

1.36

361

1023

(3007164) IgA [Mass/volume] in Serum or Plasma

2983

20651

1.64

100.43

1.6

1.5

2.22

2.24

g/l

0.26

1845

13177

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1593

9290

1.85

99.09

2.1

1.8

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

509

1863

2.83

98.55

1.1

6.28

5.83

u/ml

0.19

325

873

(3018418) pH of Serum or Plasma

3350

23984

1.60

97.66

4.9

4.2

7.40

0.01

2381

16960

(3019550) Sodium [Moles/volume] in Serum or Plasma

9151

84049

2.35

97.28

23.5

15.6

139.55

139.64

mmol/l

3.22

9056

82377

(40768797) Stomach Pathology biopsy report

1868

11554

1.76

95.09

1.3

1.2

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

9155

84222

2.33

94.84

23.8

15.8

3.92

3.94

mmol/l

14.30

9045

82361

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1507

8779

1.85

93.59

2.2

1.8

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

8776

79681

1.97

90.71

19.8

13.2

88.06

86.84

ml/min/173m2

6.12

8201

72745

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1351

7681

1.88

90.37

5.1

4.5

5.79

5.81

kpa

0.26

1323

7487

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

459

1683

2.81

88.46

1.1

0.66

0.22

u/ml

1.52

241

538

(3014111) Lactate [Moles/volume] in Serum or Plasma

1232

6842

1.92

88.45

8.7

8.1

1.38

1.30

mmol/l

1.52

1218

6713

(3012544) pH of Venous blood

1355

7799

1.86

86.95

5.1

4.5

7.38

0.67

774

4505

(3002032) Base excess in Venous blood by calculation

1315

7499

1.87

86.89

5.2

4.6

1.63

1.73

mmol/l

0.43

1170

6524

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

3283

23896

1.56

86.53

1.5

1.4

1.69

1.68

u/ml

0.00

871

6762

(3012095) Magnesium [Moles/volume] in Serum or Plasma

2056

13359

1.68

86.48

4.1

3.8

0.82

mmol/l

0.86

1960

12632

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

7907

69871

1.68

86.16

5.4

4.6

14.56

14.58

pmol/l

0.24

7436

65040

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

2575

17749

1.61

85.54

1.5

1.3

26.90

29.14

iu/ml

0.35

690

5279

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1618

9924

1.75

83.68

3.0

2.9

6.25

7.38

umol/l

2.01

1368

8598

(3021601) Nitrite [Presence] in Urine by Test strip

5676

46660

1.51

83.55

4.6

3.7

0.00

estimate

0.30

1322

9820

(3009261) Glucose [Presence] in Urine by Test strip

5746

47429

1.51

82.37

4.7

3.8

0.79

0.26

estimate

0.30

1284

9521

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1481

8923

1.78

81.27

2.6

2.3

361.74

376.77

nmol/l

1.89

1388

8300

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

2396

16422

1.61

80.68

1.4

1.3

8.66

10.14

u/ml

0.56

869

6773

(3015736) pH of Urine

4732

37629

1.50

80.57

4.0

3.3

6.19

6.23

1.64

2697

21161

(3035350) Ketones [Presence] in Urine by Test strip

5705

47162

1.50

80.08

4.6

3.7

6.86

3.62

estimate

0.64

1341

9952

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2817

20093

1.56

79.77

3.2

3.1

1178.19

1122.77

ng/l

0.25

2368

17011

(3048689) Calprotectin [Mass/mass] in Stool

2046

13547

1.64

79.04

2.7

2.6

119.42

119.48

ug/g

0.00

1618

10792

(3007853) Bacteria identified in Skin by Aerobe culture

1624

10124

1.72

78.81

2.0

1.7

—

(3022948) Iron [Moles/volume] in Serum or Plasma

2115

14150

1.63

78.27

2.9

2.6

13.17

13.62

umol/l

2.02

1957

13282

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

3086

22629

1.53

76.38

2.6

2.3

2.59

2.72

mg/l

2.71

2708

19694

(3042936) Bacteria identified in Isolate by Culture

1778

11462

1.67

75.85

2.2

2.0

—

(3024354) Oxygen [Partial pressure] in Venous blood

1135

6452

1.86

75.04

4.4

4.1

4.72

4.66

kpa

0.42

1106

6281

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

4980

40380

1.47

74.60

2.9

2.5

74.32

75.70

nmol/l

2.84

4603

37351

(3021960) Folate [Moles/volume] in Serum or Plasma

3046

22369

1.52

74.43

1.8

1.6

19.57

20.20

nmol/l

1.68

2635

19285

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

8754

80331

1.84

74.32

6.7

5.5

1.78

1.83

mu/l

2.73

8342

75702

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1968

13087

1.63

74.09

2.9

2.6

2.41

2.39

g/l

0.81

1784

12146

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1040

5772

1.90

74.05

1.7

—

(3014051) Protein [Presence] in Urine by Test strip

3475

26295

1.50

73.28

3.4

2.8

0.04

0.05

0.07

480

(3001122) Ferritin [Mass/volume] in Serum or Plasma

5632

46881

1.47

73.09

3.8

3.3

100.33

97.69

ug/l

0.37

5296

44359

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1821

11921

1.65

72.84

3.0

2.6

22.02

23.02

2.49

1662

11136

(3015377) Calcium [Moles/volume] in Serum or Plasma

3697

28395

1.48

72.09

3.6

3.4

2.35

mmol/l

0.15

3396

26054

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

902

4833

1.95

71.26

5.2

5.0

24.26

24.17

mmol/l

0.36

895

4788

(3000936) Kiwifruit IgE Ab [Units/volume] in Serum

25.12

71.24

1.0

0.77

0.43

u/ml

0.27

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

1096

6261

1.84

71.12

1.6

1.5

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

6993

61000

1.51

70.23

4.1

3.2

44.86

41.02

u/l

3.22

6673

57981

(3026493) Urate [Moles/volume] in Serum or Plasma

2861

20966

1.51

69.59

2.8

2.6

331.54

326.23

umol/l

2.08

2543

18834

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

993

5578

1.87

67.81

10.0

9.4

24.82

24.78

mmol/l

0.15

987

5552

(3044640) Blood type and Crossmatch panel - Blood

3626

28163

1.46

64.74

2.8

2.3

—

(3005719) IgG [Mass/volume] in Serum or Plasma

1182

7166

1.74

62.23

2.9

10.19

10.45

g/l

1.48

1101

6663

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

827

4522

1.91

61.13

1.9

1.7

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

7110

63050

1.47

58.67

4.2

3.4

—

(3023420) DNA double strand Ab [Units/volume] in Serum

750

4045

1.92

57.69

2.1

1.9

7.16

6.89

iu/ml

0.08

162

980

(3020564) Creatinine [Moles/volume] in Serum or Plasma

9379

89351

2.17

52.88

25.8

17.3

73.51

72.65

umol/l

1.73

9327

88374

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

4916

41308

1.38

51.90

3.2

2.8

—

estimate

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

576

2945

2.02

51.59

1.2

1.3

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2795

21382

1.43

51.12

2.7

2.3

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1063

6608

1.68

50.43

2.5

2.4

18.87

21.09

au/ml

0.44

110

794

(3019309) Folate [Moles/volume] in Red Blood Cells

1728

12066

1.52

50.23

1.9

1.7

1086.89

1168.82

nmol/l

3.39

1336

9291

(3028026) IgM [Mass/volume] in Serum or Plasma

929

5577

1.74

50.09

2.0

1.9

1.40

1.30

g/l

0.64

859

5196

(3000494) Fungus identified in Specimen by Culture

1536

10464

1.55

49.96

1.6

1.5

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

119

6.68

49.93

1.1

18.42

0.54

u/ml

0.51

(3009445) Proteinase 3 Ab [Units/volume] in Serum

638

3424

1.92

49.62

1.4

1.6

6.89

12.80

iu/ml

—

106

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1332

8798

1.59

49.52

4.1

4.6

226.79

241.21

u/l

4.05

1266

8363

(3017958) Strawberry IgE Ab [Units/volume] in Serum

14.73

49.31

1.0

0.21

0.07

u/ml

0.46

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

14.12

49.29

1.1

1.0

0.06

0.04

u/ml

0.47

(3022145) Colonoscopy Study observation

1439

9689

1.57

49.23

1.4

—

(40768804) Tissue Pathology biopsy report

4237

34963

1.37

48.94

2.2

2.1

—

(3003396) Base excess in Arterial blood by calculation

1261

8282

1.60

47.89

9.0

8.0

0.77

0.81

mmol/l

0.11

1067

6759

(40760892) CBC W Ordered Manual Differential panel - Blood

2755

21231

1.41

47.66

5.1

4.5

—

(3021440) Promyelocytes/Leukocytes in Blood

1133

7270

1.63

47.32

4.9

4.7

0.10

0.12

0.29

315

1839

(3002179) Metamyelocytes/Leukocytes in Blood

1129

7249

1.63

47.01

4.6

4.5

0.56

0.67

0.98

346

2036

(3017181) Myelocytes/Leukocytes in Blood

1169

7572

1.62

46.97

4.8

4.7

0.85

0.92

0.27

353

2135

(3025159) Blasts/Leukocytes in Blood

1148

7416

1.62

46.61

5.0

4.9

0.13

0.27

0.53

301

1770

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

989

6157

1.67

46.46

1.4

1.3

39.43

50.68

au/ml

0.85

375

(3016502) Oxygen saturation in Arterial blood

1140

7366

1.62

46.22

9.4

8.5

95.42

95.90

1.38

1107

7093

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1085

6929

1.64

46.12

9.7

8.9

122.99

121.41

g/l

1.72

1068

6758

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

148

407

3.68

46.07

1.0

13.78

11.52

u/ml

0.42

277

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

528

2733

1.98

45.60

1.4

1.3

9.91

8.84

u/ml

0.10

410

(3019977) pH of Arterial blood

1259

8358

1.58

45.53

9.1

8.1

7.42

0.01

628

4497

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1256

8353

1.58

45.03

9.0

8.0

5.09

5.08

kpa

0.18

1216

8033

(3027801) Oxygen [Partial pressure] in Arterial blood

1255

8351

1.58

44.88

9.0

8.0

12.38

12.92

kpa

3.04

1216

8031

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

525

2734

1.97

44.54

1.4

1.3

5.46

5.39

u/ml

0.01

255

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1521

10588

1.52

44.29

7.6

6.4

1.06

mmol/l

0.06

1458

9882

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

555

2956

1.93

44.07

1.4

1.3

36.88

37.98

u/ml

0.03

179

(3009508) Creatinine [Moles/volume] in Urine

3380

27253

1.37

43.60

3.8

3.4

7.61

7.67

mmol/l

0.30

2867

23502

(3027945) Reticulocytes/Erythrocytes in Blood

1272

8543

1.56

43.59

2.8

2.9

1.77

1.76

0.07

1143

7662

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

7975

73543

1.45

43.27

25.7

17.2

13.56

13.46

9.54

7928

72608

(3011397) Hemoglobin [Presence] in Urine by Test strip

2737

21347

1.39

43.26

4.3

3.6

0.22

0.18

—

184

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

742

4360

1.76

42.91

11.4

10.2

24.30

24.22

mmol/l

0.27

732

4283

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

449

2244

2.05

42.75

1.4

1.5

18.45

11.89

iu/ml

0.37

(3013139) Helicobacter pylori Ag [Presence] in Stool

999

6365

1.63

42.69

1.2

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

2074

15450

1.43

42.54

2.9

2.8

2.44

mmol/l

0.30

1852

13841

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

430

2124

2.07

42.26

2.2

0.02

g/l

0.03

404

1925

(3020779) Urea [Moles/volume] in Serum or Plasma

1048

6775

1.61

42.19

9.1

8.3

8.65

8.86

mmol/l

0.46

1014

6530

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

869

5366

1.68

41.93

5.2

4.4

5.15

5.13

kpa

0.33

840

5163

(3009343) pH of Capillary blood

850

5221

1.69

41.84

5.2

4.4

7.42

7.41

0.80

727

4308

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

394

1891

2.13

41.77

2.3

0.00

g/l

-0.00

381

1788

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

534

2863

1.91

41.54

2.3

7.24

7.38

g/l

1.12

509

2646

(3004119) Hemoglobin [Mass/volume] in Venous blood

757

4520

1.73

41.33

4.0

3.7

130.37

129.91

g/l

0.23

739

4396

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

533

2861

1.91

41.31

2.3

4.24

4.25

g/l

0.11

508

2646

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

512

2712

1.94

41.30

2.2

2.3

2.88

g/l

0.04

487

2498

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

532

2860

1.91

41.04

2.3

3.77

3.69

g/l

0.51

505

2646

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1176

7868

1.56

40.81

1.3

1.2

142.76

144.37

u/ml

0.03

410

3025

(3015171) Extractable nuclear Ab [Units/volume] in Serum

669

3870

1.78

40.78

1.3

1.61

1.09

u/ml

0.27

296

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

9304

89138

1.87

39.94

15.1

11.2

26.32

25.75

u/l

2.26

9161

86938

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

763

4608

1.71

39.93

5.1

4.4

1.86

1.60

mmol/l

1.34

572

3385

(3018001) Oat IgE Ab [Units/volume] in Serum

7.14

39.73

1.1

1.0

1.77

0.17

u/ml

0.53

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

708

4194

1.74

39.72

10.7

10.4

16.21

16.06

0.75

694

4032

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

469

2444

1.97

39.67

2.3

10.07

10.21

g/l

0.31

440

2214

(3024928) Oxygen saturation in Venous blood

395

1938

2.08

39.52

3.2

4.3

62.76

62.48

0.09

381

1881

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

409

2033

2.06

39.51

2.2

0.00

g/l

0.43

380

1792

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

2006

15030

1.42

39.43

2.5

2.2

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

472

2481

1.95

38.93

2.3

0.62

0.81

g/l

0.70

434

2153

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

636

3674

1.78

38.92

1.6

14.98

12.51

u/ml

0.37

127

954

(3020630) Protein [Mass/volume] in Serum or Plasma

937

6010

1.62

38.80

2.7

2.6

66.82

66.65

g/l

0.28

884

5571

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

255

1054

2.46

38.52

1.2

1.3

0.18

0.19

nmol/l

0.39

169

816

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

439

2259

1.99

38.50

1.3

7.58

3.63

u/ml

0.47

151

(3007456) Orange IgE Ab [Units/volume] in Serum

12.80

38.27

1.1

1.0

0.05

0.11

u/ml

0.60

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

8240

76873

1.45

38.18

6.7

5.6

38.64

38.18

mmol/mol

4.91

7832

72823

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

334

1559

2.18

38.02

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

334

1559

2.18

38.02

1.4

1.3

—

(3017732) Neutrophils [#/volume] in Blood

1571

11319

1.46

38.00

3.2

3.1

4.34

4.39

e9/l

0.22

1375

9976

(3052851) Hemolysis interference index of Serum or Plasma

426

2180

2.00

37.95

3.1

3.0

1.74

2.18

index

0.59

237

1120

(40768443) Skin Pathology biopsy report

653

3830

1.76

37.90

1.2

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

2153

16427

1.40

37.89

2.7

2.3

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

471

2501

1.93

37.69

1.4

292.82

285.96

ug/g

0.27

250

1388

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

280

1219

2.33

37.67

1.2

1.3

0.51

3.29

nmol/l

0.96

269

1182

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

8434

79108

1.48

37.28

5.3

4.6

5.86

5.78

mmol/l

7.47

7905

73834

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

61.68

37.10

1.0

1.1

0.68

0.70

u/ml

—

(3025941) Bacteria identified in Stool by Culture

822

5171

1.64

36.73

1.3

1.2

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

480

2589

1.90

36.62

2.5

2.3

240.11

546.10

ug/l

2.65

443

2435

(3041096) Erythrocytes [Presence] in Urine by Automated

3209

26203

1.33

36.31

3.9

3.1

0.02

0.15

estimate

1.65

1134

7952

(3014007) Fractional oxyhemoglobin in Arterial blood

767

4758

1.66

36.19

11.5

10.2

93.85

94.23

0.82

767

4740

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

282

1255

2.28

36.05

1.2

1.3

0.23

0.25

nmol/l

0.08

(3048929) Epstein Barr virus Ab [Presence] in Serum

660

3946

1.72

35.74

1.4

1.3

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

708

4323

1.69

35.47

2.2

1.9

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1606

11762

1.44

35.35

2.0

1.7

1.47

1.40

3.42

1396

10489

(36660697) Celiac disease serology panel - Serum

1207

8373

1.50

35.09

1.2

—

(3036489) Thrombin time

598

3503

1.75

34.81

2.3

2.6

20.34

20.93

2.07

537

3048

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

10.92

34.62

1.1

0.16

0.10

u/ml

0.20

(40767503) Oxygen content in Capillary blood by calculation

328

1583

2.11

34.28

3.3

2.5

16.74

16.62

0.32

318

1550

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

464

2538

1.87

33.89

1.3

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

428

2294

1.91

33.28

1.3

—

(3023520) Reticulocytes [#/volume] in Blood

961

6420

1.55

33.20

2.8

69.83

70.10

e9/l

0.08

673

4604

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

4162

35536

1.30

33.16

4.4

3.6

0.13

0.26

estimate

0.42

1113

8131

(3021901) Oxygen saturation in Capillary blood

318

1540

2.10

32.95

3.6

3.2

91.61

90.73

2.08

311

1505

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

9.78

32.95

1.1

0.17

0.11

u/ml

0.23

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

391

2046

1.95

32.66

1.7

1.6

—

(3023511) Choriogonadotropin [Units/volume] in Urine

534

3085

1.77

32.59

1.5

1.4

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

423

2279

1.89

32.37

1.3

51.68

46.60

u/ml

0.23

224

(3015235) Bicarbonate [Moles/volume] in Capillary blood

474

2648

1.83

32.35

3.7

3.3

24.59

24.69

mmol/l

0.24

465

2606

(3028707) Methadone [Presence] in Urine by Screen method

425

2295

1.89

32.30

2.9

2.6

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

325

1611

2.05

31.64

1.7

1.6

0.65

0.72

g/l

0.74

263

1264

(3017143) Hepatitis C virus Ab [Presence] in Serum

1704

12835

1.40

31.61

1.7

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

471

2650

1.82

31.41

1.2

1.1

—

(3020682) Albumin/Creatinine [Ratio] in Urine

2924

23942

1.32

31.31

4.6

4.2

16.75

8.88

mg/mmol

0.69

1810

14912

(3017166) Chili Pepper IgE Ab [Units/volume] in Serum

31.66

31.21

1.0

0.15

0.03

u/ml

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

612

3720

1.69

31.11

1.9

2.0

38.55

39.69

u/l

0.81

571

3387

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1106

7716

1.49

31.04

3.9

3.1

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

279

1318

2.15

30.84

1.3

1.2

35.00

16.01

u/ml

0.50

(3028271) Lactate [Moles/volume] in Capillary blood

256

1170

2.22

30.74

2.3

1.8

1.70

1.66

mmol/l

0.27

247

1139

(1616796) Gas panel - Central venous blood

341

1747

1.99

30.29

4.2

3.7

—

(3035637) Corticotropin [Mass/volume] in Plasma

272

1292

2.14

29.66

1.8

1.7

28.52

29.95

ng/l

0.12

272

1287

(3019230) Fractional oxyhemoglobin in Venous blood

331

1692

1.99

29.60

3.3

4.2

61.41

62.51

0.41

331

1686

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

827

5479

1.56

29.53

2.6

2.3

4.67

7.24

ug/l

6.78

714

4804

(3012516) Albumin [Mass/volume] in Urine

2873

23620

1.31

29.46

3.8

3.5

56.67

49.92

mg/l

0.64

1845

14940

(3045414) Leukocytes [Presence] in Urine

1159

8256

1.46

29.14

2.2

2.0

0.01

0.03

estimate

0.70

235

1841

(3007542) Rye IgE Ab [Units/volume] in Serum

6.64

28.42

1.1

1.0

33.64

0.11

u/ml

0.51

(3028626) Oxygen [Partial pressure] in Capillary blood

422

2370

1.82

28.31

6.1

5.0

8.62

8.73

kpa

0.67

409

2318

(3000330) Specific gravity of Urine by Test strip

623

3904

1.64

28.10

3.5

3.1

1.02

ratio

0.48

550

3457

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

485

2845

1.74

28.04

2.7

2.9

180.60

182.44

0.18

460

2706

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

389

2139

1.85

27.94

1.7

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

583

3607

1.66

27.65

1.4

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

942

6506

1.50

27.63

3.3

3.5

4.52

4.55

pmol/l

0.39

866

5898

(44816559) Phosphatidylethanol [Mass/volume] in Blood

634

4009

1.62

27.57

1.7

0.35

0.29

mg/l

1.89

270

1752

(3014765) Yersinia sp identified in Stool by Organism specific culture

427

2426

1.79

27.56

1.2

1.1

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

912

6261

1.50

27.54

2.9

2.3

8435.78

6190.23

u/l

0.84

331

2499

(3027315) Oxygen [Partial pressure] in Blood

307

1572

1.98

27.34

4.2

4.1

8.88

8.80

kpa

0.30

302

1545

(3012501) Base excess in Blood by calculation

305

1563

1.98

27.10

4.2

4.1

2.01

2.44

mmol/l

2.53

193

1021

(3013290) Carbon dioxide [Partial pressure] in Blood

305

1564

1.98

27.05

4.2

4.1

4.96

5.00

kpa

0.58

300

1538

(4062490) Immunoglobulin typing, IgG

219

991

2.24

26.99

1.6

1.3

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

560

3453

1.66

26.91

5.3

3.9

51.29

48.55

1.83

550

3396

(42529406) Shigella sp [Presence] in Stool by Culture

426

2438

1.78

26.83

1.2

1.1

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

764

5078

1.55

26.81

1.2

1.1

37.37

2.88

u/ml

—

(3007700) Barley IgE Ab [Units/volume] in Serum

7.04

26.66

1.1

1.0

31.89

0.68

u/ml

0.48

(46235355) HIV 1 and 2 tests - Meaningful Use set

2840

23558

1.29

26.60

2.3

2.1

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

228

1057

2.18

26.48

1.7

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

464

2733

1.73

26.44

1.3

1.2

3.92

4.21

0.28

406

(44813793) Dust mix specific IgE antibody measurement

175

730

2.42

26.03

1.1

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

220

1014

2.20

25.93

1.6

1.3

0.31

0.39

g/l

5.48

167

736

(3027135) IgG subclass 1 [Mass/volume] in Serum

220

1014

2.20

25.93

1.6

1.3

6.25

6.61

g/l

0.93

169

740

(3028192) IgG subclass 2 [Mass/volume] in Serum

220

1015

2.19

25.87

1.6

1.3

2.63

2.95

g/l

2.35

169

740

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

273

1372

2.02

25.64

1.7

1.8

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1167

8528

1.42

25.33

1.5

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1085

7833

1.43

25.19

2.5

2.4

0.22

g/l

0.93

1018

7354

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

897

6252

1.48

25.05

4.4

3.8

1.23

mmol/l

1.12

770

5410

(3010421) pH of Blood

422

2459

1.75

24.98

4.0

3.7

7.41

0.30

417

2435

(3002256) Pathology report gross observation

1478

11283

1.36

24.64

1.3

—

(3035933) Granulocytes/Leukocytes in Blood

363

2042

1.81

24.24

3.2

3.3

58.34

57.43

0.76

363

2042

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

413

2413

1.74

24.22

1.2

1.1

—

(3007461) Platelets [#/volume] in Blood

9560

93389

1.99

24.09

32.2

21.6

263.24

259.05

e9/l

8.55

9457

91724

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

874

6114

1.47

23.92

5.0

4.0

90.91

83.16

ng/l

1.56

765

5374

(3024731) MCV [Entitic mean volume] in Red Blood Cells

9561

93414

1.98

23.89

32.0

21.5

90.54

90.49

0.50

9525

92628

(3026361) Erythrocytes [#/volume] in Blood

9561

93426

1.98

23.70

32.1

21.5

4.49

4.50

e12/l

0.82

9435

91552

(3035941) MCH [Entitic mass]

9560

93415

1.98

23.66

32.0

21.5

30.12

30.16

1.09

9523

92631

(3000963) Hemoglobin [Mass/volume] in Blood

9562

93445

1.98

23.60

32.4

21.7

134.28

134.89

g/l

4.58

9528

92678

(3011288) Drugs identified in Urine by Screen method Nominal

604

3926

1.57

23.35

3.7

2.6

—

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

9559

93424

1.96

23.30

32.9

21.9

40.23

40.93

3.98

9525

92595

(3010813) Leukocytes [#/volume] in Blood

9560

93443

1.96

23.20

32.2

21.6

6.99

6.70

e9/l

27.34

9438

91527

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

492

3052

1.64

23.07

2.6

3.2

95.52

94.06

0.75

473

2939

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

401

2356

1.73

23.06

1.9

2.1

11.25

11.28

mg/l

0.03

385

2216

(3011985) Renin [Units/volume] in Plasma

247

1248

2.00

22.90

1.6

78.69

65.33

mu/l

0.24

227

1122

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

376

2177

1.76

22.78

3.5

4.5

0.35

0.34

iu/ml

0.20

192

1175

(3022621) pH of Urine by Test strip

975

7026

1.43

22.76

2.7

2.5

6.03

6.12

2.39

615

4546

(1001926) Buprenorphine [Presence] in Urine by Screen method

651

4336

1.54

22.56

2.5

2.1

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

530

3370

1.61

22.49

2.0

1.8

1.58

1.48

g/l

1.47

463

2908

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

8193

77796

1.32

22.36

4.3

3.9

1.34

1.25

mmol/l

23.37

7664

72927

(3029937) Albumin [Presence] in Urine by Test strip

2980

25280

1.26

22.31

4.8

3.9

0.01

0.00

estimate

0.23

1266

9245

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

759

5234

1.49

22.29

3.1

3.0

147.05

165.44

ng/l

0.73

680

4748

(3030981) Hyaline casts [#/volume] in Urine by Automated count

895

6377

1.44

22.20

2.7

2.4

0.43

0.37

e6/l

0.31

851

6055

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

394

2329

1.72

22.18

1.4

1.3

51.75

55.21

u/ml

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

180

818

2.22

22.03

1.2

—

(3042951) Complement C1q Ab [Units/volume] in Serum

7.04

22.01

1.1

9.53

29.70

u/ml

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

230

1152

2.02

21.86

1.5

1.4

763.55

389.38

pmol/l

0.41

203

1000

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

2035

16516

1.29

21.80

1.9

1.7

21553156.43

30898269.69

pmol/l

0.40

1726

14056

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

812

5708

1.46

21.61

1.1

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

374

2197

1.73

21.54

1.7

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

177

811

2.20

21.25

1.2

—

(3008898) HLA-B27 [Presence]

600

3977

1.54

21.25

1.1

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

181

837

2.18

21.24

1.2

—

(3021788) Differential panel - Synovial fluid

269

1437

1.90

21.21

1.7

1.6

—

1.00

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

177

812

2.20

21.19

1.2

—

(3022806) Fractional oxyhemoglobin in Capillary blood

191

904

2.13

21.14

2.1

1.8

90.57

90.16

0.44

186

890

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

443

2740

1.65

21.02

1.3

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

372

2199

1.72

20.95

1.5

1.3

282.80

249.96

u/ml

0.96

230

1375

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

463

2909

1.62

20.64

3.0

3.2

3.54

g/l

0.03

437

2763

(3021387) Prolactin [Units/volume] in Serum or Plasma

701

4836

1.48

20.51

1.8

1.7

334.01

312.82

mu/l

0.69

637

4364

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

193

929

2.10

20.46

1.3

1.2

—

(40761536) Microorganisms panel - Urine sediment

990

7284

1.40

20.44

5.0

3.7

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

136

568

2.41

20.28

2.6

3.1

85.55

145.60

nmol/l

0.85

131

562

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

8675

83310

1.36

20.05

5.8

5.1

2.75

2.77

mmol/l

2.11

8199

78745

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

204

1011

2.04

20.00

1.7

1.6

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

109

416

2.64

19.64

3.4

2.4

233.71

151.96

umol/l

1.01

217

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

169

786

2.17

19.58

1.2

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

399

2449

1.66

19.53

1.4

1.5

490.11

501.45

mg/l

0.08

387

2340

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

189

920

2.07

19.47

1.3

1.2

60.11

46.37

u/ml

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

100

367

2.74

19.45

1.2

1.1

3.10

4.04

iu/ml

—

(3029075) Extractable nuclear Ab panel - Serum

143

624

2.31

19.33

1.1

—

0.32

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

168

785

2.16

19.25

1.2

—

(3028300) Cannabinoids [Presence] in Urine

787

5623

1.43

19.15

2.5

2.0

—

(3016879) Cocaine [Presence] in Urine

730

5151

1.45

19.00

2.5

2.0

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

324

1896

1.73

18.95

1.6

1.5

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

230

1214

1.92

18.85

1.1

1.2

—

(3027008) Opiates [Presence] in Urine

783

5607

1.43

18.81

2.4

1.9

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

8552

82095

1.33

18.65

5.1

4.6

1.43

1.49

mmol/l

28.61

8072

77531

(3000764) Benzodiazepines [Presence] in Urine

777

5575

1.43

18.46

2.5

2.0

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1367

10733

1.32

18.42

2.3

2.1

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

477

3103

1.56

18.37

4.6

3.4

25.16

25.25

mmol/l

0.28

465

2991

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

359

2180

1.67

18.33

1.3

1.5

3.57

3.65

mmol/l

1.08

343

2059

(3018333) Ribosomal P Ab [Presence] in Serum

162

762

2.14

18.28

1.2

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

335

2000

1.70

18.23

1.5

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

8582

82520

1.32

17.74

5.2

4.6

4.64

4.70

mmol/l

6.27

8144

78300

(3047007) Chlamydophila sp Ab [Presence] in Serum

274

1560

1.78

17.66

1.2

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

210

1100

1.93

17.64

1.4

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

273

1556

1.78

17.53

1.5

1.4

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

2337

19716

1.24

17.51

1.8

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

374

2323

1.63

17.49

2.5

2.7

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

318

1895

1.70

17.44

6.2

686.64

550.24

iu/ml

0.11

239

(3020191) Ethanol [Moles/volume] in Serum or Plasma

153

718

2.15

17.39

1.6

1.5

1.25

1.20

promille

0.14

114

564

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

206

1078

1.93

17.36

1.4

—

(3027944) Amphetamines [Presence] in Urine

767

5554

1.41

17.29

2.3

2.0

—

(3020961) Endomysium IgA Ab [Titer] in Serum

725

5198

1.43

17.28

1.1

114.17

224.24

titre

1.02

151

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

423

2720

1.58

17.14

2.1

1.9

1.47

2.18

ug/l

1.11

371

2424

(3019225) pH of Specimen

960

7230

1.36

17.07

4.4

4.0

7.37

7.35

3.12

725

5162

(3004809) Band form neutrophils/Leukocytes in Blood

228

1244

1.85

16.91

3.4

3.5

1.12

1.52

1.46

195

1134

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

328

1988

1.67

16.89

3.0

3.2

3.75

2.47

ratio

0.45

161

1126

(3008037) Lactate [Moles/volume] in Venous blood

278

1613

1.74

16.80

4.0

3.0

1.49

1.51

mmol/l

0.17

270

1563

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

197

1030

1.93

16.66

1.4

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

359

2236

1.63

16.62

3.1

3.4

34.48

50.16

mg/l

1.29

302

1906

(3025468) Yersinia sp identified in Specimen by Organism specific culture

196

1024

1.93

16.62

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

197

1032

1.93

16.57

1.4

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

359

2239

1.63

16.53

3.1

3.4

48.93

72.26

mg/l

0.47

302

1908

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

128

571

2.26

16.50

1.6

—

(3020934) Sesame Seed IgE Ab [Units/volume] in Serum

16.29

16.50

1.0

3.68

0.54

u/ml

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

276

1607

1.74

16.48

1.3

1.2

3.14

3.49

u/ml

0.15

105

595

(3017354) Segmented neutrophils/Leukocytes in Blood

162

795

2.06

16.40

3.0

3.4

58.07

56.87

0.31

134

695

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

248

1402

1.79

16.40

1.2

1.3

197.38

348.40

titre

0.99

119

(3023419) Bacteria identified in Sputum by Culture

182

934

1.97

16.27

2.7

3.0

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

203

1081

1.90

16.26

1.4

—

(3004616) Nuclear Ab [Presence] in Serum

213

1153

1.87

16.22

1.4

1.3

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1146

8927

1.32

16.21

2.1

2.0

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

476

3191

1.52

16.00

4.7

5.1

1.67

1.62

0.50

456

3000

(3022313) Gas panel - Capillary blood

541

3736

1.47

15.73

5.7

4.6

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

146

701

2.10

15.69

1.2

1.3

193.75

206.69

titre

0.06

130

(3002079) Sodium [Moles/time] in 24 hour Urine

101

417

2.44

15.55

1.2

1.3

163.32

155.34

mmol/24h

0.49

101

417

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

309

1891

1.65

15.36

1.2

1.1

12.11

15.89

au/ml

0.66

496

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

266

1565

1.72

15.33

1.3

1.2

3.52

4.05

u/ml

0.36

127

700

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

550

3832

1.46

15.28

2.4

2.3

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

3921

35171

1.19

15.17

2.0

1.9

1.43

1.35

mmol/l

7.19

3361

30236

(3039162) Centromere protein B Ab [Units/volume] in Serum

220

1232

1.80

15.05

1.4

1.3

42.29

60.64

u/ml

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

253

1476

1.73

15.04

1.1

2.98

2.71

0.11

254

(3042517) Benzodiazepines panel - Urine

134

3.59

14.86

2.6

2.4

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

467

3170

1.50

14.80

1.7

1.6

1.91

8.53

iu/ml

0.51

560

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

255

1499

1.72

14.76

4.0

3.6

360.33

1092.13

u/ml

1.21

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

342

2174

1.59

14.60

1.4

1.7

2635.58

2823.49

e6/l

0.03

271

1699

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

152

762

2.01

14.57

1.7

2.5

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

259

1535

1.71

14.56

1.1

—

(3038026) Centromere Ab [Units/volume] in Serum

137

664

2.08

14.40

1.3

1.2

65.03

48.39

u/ml

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

337

2143

1.59

14.37

1.3

1.6

17.79

26.62

e6/l

0.67

252

1571

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

452

3069

1.50

14.31

5.9

4.8

25.02

24.60

mmol/l

2.77

426

2881

(3007930) Methemoglobin/Hemoglobin.total in Blood

433

2917

1.51

14.25

5.0

5.4

0.87

0.89

0.43

415

2741

(3006184) Hemoglobin [Mass/volume] in Capillary blood

305

1898

1.63

14.22

2.9

2.2

130.44

130.12

g/l

0.09

239

1492

(4024509) Urine culture

555

3929

1.44

14.18

2.1

1.9

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

116

531

2.20

14.12

1.3

1.5

4.89

6.03

u/l

1.70

102

458

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

138

676

2.06

14.11

3.6

4.2

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

447

3038

1.49

14.09

2.2

2.0

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

209

1177

1.79

14.06

1.5

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

247

1463

1.71

13.93

1.1

120.68

115.54

1.73

222

1329

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

257

1544

1.68

13.76

1.8

1.6

—

(3045424) Erythrocytes [Presence] in Urine

589

4239

1.41

13.73

2.1

0.02

0.19

estimate

0.51

189

1466

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

151

773

1.97

13.67

1.3

1.2

64.25

71.03

u/ml

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

335

2154

1.57

13.64

1.6

1.5

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

701

5204

1.37

13.59

1.4

—

(3000475) Leukocytes [#/volume] in Synovial fluid

303

1905

1.61

13.57

1.8

1.7

14580.80

11534.57

e6/l

0.40

190

1346

(4198724) Urine methamphetamine measurement

113

521

2.18

13.53

2.4

2.9

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

167

890

1.89

13.43

2.8

3.3

5.14

10.93

nmol/l

0.45

158

860

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

195

1096

1.79

13.23

1.2

1.1

97.79

95.23

0.58

181

1032

(3023183) Ammonium ion [Moles/volume] in Plasma

271

1668

1.64

13.23

2.5

3.0

32.56

34.70

umol/l

0.84

251

1531

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

245

1469

1.68

13.23

1.7

1.6

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

904

7012

1.32

13.08

1.4

22.54

24.64

iu/l

1.23

770

5962

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

258

1582

1.65

12.80

1.4

1.3

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

443

2.25

12.78

1.1

10.94

9.15

u/ml

0.19

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

328

2152

1.54

12.25

1.6

1.4

8.26

23.29

u/ml

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

257

1594

1.63

12.20

1.5

1.4

—

(3003740) Influenza virus B Ag [Presence] in Specimen

325

2131

1.54

12.18

1.1

—

(44790047) Parainfluenza type 1 nucleic acid detection

192

1102

1.76

12.17

1.8

1.6

—

(44790048) Parainfluenza type 2 nucleic acid detection

192

1102

1.76

12.17

1.8

1.6

—

(44806118) Parainfluenza type 4 nucleic acid detection

192

1102

1.76

12.17

1.8

1.6

—

(44790049) Parainfluenza type 3 nucleic acid detection

192

1102

1.76

12.17

1.8

1.6

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

254

1580

1.62

11.93

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

324

2133

1.54

11.93

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

287

1842

1.57

11.83

1.6

1.5

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

106

505

2.11

11.74

1.2

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

144

768

1.89

11.62

1.6

1.4

1.67

1.49

nmol/l

1.01

128

692

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

323

2.39

11.57

1.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

100

469

2.14

11.54

1.5

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

305

2000

1.54

11.45

2.2

2.5

7.36

6.72

umol/l

0.16

223

1471

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

174

995

1.76

11.21

6.8

6.9

11.24

11.56

mg/l

0.36

167

935

(3038515) Glucose [Moles/volume] in Venous blood

217

1319

1.66

11.19

4.5

3.1

7.27

7.47

mmol/l

0.44

211

1280

(3036071) Salmonella sp Ab [Titer] in Serum

322

2.37

11.19

1.1

—

(1002224) Polysomnography panel

611

4579

1.36

11.17

1.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

437

2.16

11.11

1.1

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

107

523

2.06

11.11

2.3

2.2

2.10

1.85

umol/l

2.26

102

484

(3020717) Zinc [Moles/volume] in Serum or Plasma

123

633

1.95

11.06

1.8

1.6

17.89

22.38

umol/l

1.30

111

586

(4195642) Thrombophilia screening test

236

1471

1.62

11.03

1.2

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

122

627

1.96

11.01

1.5

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

122

627

1.96

11.01

1.5

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

122

627

1.96

11.01

1.5

1.6

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

138

742

1.87

10.89

1.9

2.4

—

(3049717) Cytology report of Urine Cyto stain

332

2242

1.50

10.87

2.6

2.5

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

398

2787

1.45

10.84

2.1

1.9

—

(3020891) Body temperature

459

3299

1.41

10.83

5.1

4.2

36.95

36.92

°c

1.15

454

3272

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

302

2002

1.52

10.80

1.7

1.5

158.77

141.03

au/ml

1.92

578

(3016650) Hepatitis A virus Ab [Presence] in Serum

251

1597

1.59

10.78

1.1

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

405

2860

1.43

10.55

1.9

2.1

3.11

8.17

iu/l

1.00

154

1263

(43055442) Apixaban [Mass/volume] in Serum or Plasma

3.63

10.49

1.5

1.6

128.22

121.58

ug/l

0.10

(3003181) Sodium [Moles/volume] in Urine

222

1381

1.62

10.48

1.9

1.5

56.63

63.36

mmol/l

1.79

183

1113

(3009466) Valproate [Moles/volume] in Serum or Plasma

197

1193

1.66

10.34

5.9

5.7

362.54

369.94

umol/l

0.31

168

1044

(3007566) Smooth muscle Ab [Titer] in Serum

378

2647

1.45

10.31

1.3

118.38

122.12

titre

0.04

260

(3003694) ABO and Rh group [Type] in Blood

3138

28282

1.16

10.24

1.6

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

214

1328

1.62

10.21

1.2

1.39

1.07

0.27

(3035320) C reactive protein [Mass/volume] in Body fluid

127

681

1.88

10.14

3.4

2.6

21.66

26.25

mg/l

0.85

481

(3045142) Bone marrow Pathology biopsy report

150

848

1.78

10.10

1.4

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

570

4296

1.35

10.06

6.7

24.59

24.40

mmol/l

0.62

547

4095

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

422

2.12

10.05

1.5

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

449

2.08

10.02

1.5

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

130

708

1.85

9.90

1.3

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

129

703

1.85

9.81

1.3

1.2

—

(3023410) Appearance of Cerebral spinal fluid

174

1036

1.69

9.77

1.5

2.0

—

(3037756) Immunofixation for Serum or Plasma

211

1323

1.61

9.68

2.0

1.7

—

(3011412) CD3 cells [#/volume] in Blood

162

951

1.72

9.58

2.1

2.6

1416.54

1240.73

e6/l

1.61

134

801

(4268621) Lupus anticoagulant assay

186

1134

1.65

9.55

2.5

2.2

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

102

519

1.98

9.54

1.7

1.9

132.54

135.55

0.14

491

(3019150) Specific gravity of Urine by Refractometry

2351

20818

1.17

9.51

4.4

3.8

1.02

1.24

kg/l

1.08

1608

13554

(21494815) CD4 cells/Lymphocytes in Specimen

146

836

1.76

9.44

1.9

2.5

43.52

39.90

2.43

140

828

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

157

920

1.72

9.36

2.1

2.7

23.41

19.95

nmol/l

2.64

152

881

(21491868) Cryoglobulin [Mass/volume] in Serum

317

2.25

9.34

1.3

1.2

0.14

0.21

g/l

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

7712

74354

1.17

9.33

26.3

17.7

332.08

332.48

g/l

3.65

7689

73950

(3034770) Mitochondria Ab [Titer] in Serum

367

2607

1.42

9.30

1.3

891.00

1037.23

titre

—

(3010838) Calcium [Moles/time] in 24 hour Urine

234

1522

1.55

9.20

1.8

2.0

4.67

5.12

mmol/24h

1.52

209

1376

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

154

904

1.71

9.14

1.2

1.6

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

250

1655

1.52

9.07

1.6

1.7

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

149

877

1.71

8.77

1.1

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

365

2.12

8.76

1.4

87.31

221.35

nmol/24h

0.89

365

(3033923) Metanephrine [Moles/time] in 24 hour Urine

140

2.86

8.71

1.1

0.65

0.69

umol/24h

0.27

(3047181) Lactate [Moles/volume] in Blood

317

2220

1.44

8.70

5.2

5.8

1.35

1.28

mmol/l

0.73

288

1949

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

144

846

1.71

8.55

1.1

6.59

8.80

iu/ml

0.40

221

(3038177) Helicobacter pylori Ab [Presence] in Serum

248

1665

1.50

8.45

1.2

—

(37208534) Antinuclear antibody arbitrary concentration in serum

325

2.16

8.41

1.0

1.1

—

(3016330) Potassium [Moles/time] in 24 hour Urine

111

3.07

8.37

1.1

1.3

—

96.20

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

117

3.00

8.28

1.1

1.3

31.66

42.89

mg/l

0.97

101

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

130

754

1.73

8.10

1.3

1.74

2.00

mmol/l

3.97

122

706

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

459

1.95

8.08

1.2

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

385

2.03

8.01

1.8

1.9

146.53

155.86

0.40

361

(3017315) Amylase [Enzymatic activity/volume] in Urine

426

1.98

8.01

1.5

1.2

223.17

269.48

u/l

0.38

395

(3024666) Lithium [Moles/volume] in Serum or Plasma

114

643

1.78

7.84

13.3

12.8

0.59

0.60

mmol/l

0.32

106

589

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

901

7434

1.23

7.82

4.1

4.2

19.02

26.78

ug/l

0.29

704

5851

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

374

2756

1.37

7.70

1.1

4.19

6.06

eliau/ml

0.69

386

(3006442) Creatine [Moles/volume] in Serum or Plasma

517

1.87

7.68

1.4

70.18

75.91

umol/l

1.71

517

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

191

1242

1.55

7.59

1.1

1.46

1.49

g/l

0.51

184

1129

(3037121) Protein [Mass/volume] in Urine

381

2825

1.36

7.55

3.7

3.4

263.78

448.26

mg/l

2.63

188

1293

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

131

779

1.69

7.50

1.3

73.08

79.80

0.31

(4094501) Cardiovascular stress test using bicycle ergometer

294

2090

1.42

7.49

1.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

321

2.09

7.48

4.5

4.2

—

(3051611) Lipemic interference index of Serum or Plasma

126

742

1.71

7.48

3.7

3.4

14.56

13.87

index

0.27

456

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

382

2.00

7.46

1.4

1.8

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

382

2.00

7.46

1.4

1.8

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

382

2.00

7.46

1.4

1.8

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

383

1.99

7.41

1.4

1.8

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

511

1.85

7.32

1.2

—

(3003129) Base excess in Capillary blood by calculation

142

869

1.64

7.30

2.4

2.3

0.77

0.60

mmol/l

0.25

133

832

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

123

725

1.71

7.29

2.0

2.8

227.65

214.53

e6/l

0.33

584

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

241

1662

1.46

7.25

2.6

2.2

1.04

0.83

nmol/l

2.03

200

1438

(3018405) Lactate [Moles/volume] in Arterial blood

306

2205

1.40

7.23

4.3

3.7

1.38

1.37

mmol/l

0.05

300

2161

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

150

2.61

7.17

1.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

3.67

7.17

2.3

1.5

44.45

46.80

umol/l

0.11

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

355

2627

1.36

7.14

3.6

836.66

2197.28

u/ml

0.58

307

2265

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

148

921

1.62

7.13

2.2

2.1

25.13

23.37

mg/l

0.14

338

(3008295) Osmolality of Serum or Plasma

151

946

1.61

7.08

1.7

1.5

278.78

280.06

mosm/kgh2o

0.25

105

721

(3001186) Copper [Moles/volume] in Serum or Plasma

276

2.14

7.03

1.6

1.3

17.14

16.85

umol/l

0.11

236

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

195

1297

1.51

7.02

2.4

2.6

20.55

28.38

iu/ml

0.76

101

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

484

1.85

6.95

1.1

—

(3006653) Thiamine [Moles/volume] in Blood

442

1.89

6.92

1.3

137.72

131.98

nmol/l

0.61

442

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

131

797

1.65

6.91

1.6

1.7

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

144

899

1.61

6.86

1.5

1.6

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

164

1056

1.56

6.86

1.2

1.1

1.71

2.12

iu/ml

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

221

2.27

6.84

4.4

3.9

5.13

4.87

kpa

1.08

221

(3025018) Bordetella pertussis Ab [Titer] in Serum

132

807

1.64

6.84

1.2

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

141

877

1.62

6.82

1.2

33.63

39.29

mg/l

1.35

119

743

(3026389) Candida sp identified in Specimen by Organism specific culture

214

1462

1.47

6.78

1.3

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

222

2.26

6.77

4.4

3.9

10.18

10.58

kpa

0.44

222

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

342

2.00

6.71

1.1

1.2

92.26

91.36

0.06

154

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

221

1526

1.46

6.64

1.1

3.95

3.04

eliau/ml

0.37

750

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

137

853

1.61

6.62

1.1

219.03

239.27

mg/l

0.79

121

759

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

514

1.80

6.60

1.5

31.56

21.66

u/ml

—

(1761482) Bacteria [#/volume] in Urine by Culture

226

1571

1.45

6.56

4.5

4.0

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

109

641

1.71

6.56

1.2

—

(3040151) Glucose [Moles/volume] in Capillary blood

143

902

1.59

6.55

3.8

4.5

7.75

7.09

mmol/l

0.30

121

758

(21494890) Protein electrophoresis panel - 24 hour Urine

109

642

1.71

6.52

2.2

2.1

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

727

5990

1.23

6.41

2.4

2.2

10.84

11.94

nmol/l

2.08

649

5425

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

171

2.40

6.41

1.4

1.18

mmol/l

0.01

171

(3019832) Treponema pallidum Ab [Presence] in Serum

1677

14868

1.15

6.39

1.9

1.8

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

329

1.98

6.32

1.3

1.2

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

176

1176

1.51

6.25

1.7

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

218

1524

1.44

6.17

1.1

61.33

7771.73

iu/ml

0.64

348

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

534

1.75

6.12

1.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

130

817

1.60

6.08

1.1

—

(3036048) Francisella tularensis Ab [Titer] in Serum

207

2.23

6.08

1.1

—

205.00

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

266

2.07

6.07

2.4

2.2

13.85

16.32

umol/l

0.97

266

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

349

1.93

6.02

1.1

92.00

92.32

0.03

154

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

413

1.85

6.01

1.3

1.2

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

357

2721

1.32

5.97

6.1

5.7

1.48

1.40

mg/l

1.16

331

2527

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

131

829

1.59

5.96

1.2

1.1

12.37

17.95

u/ml

1.75

344

(3014148) Varicella zoster virus Ab [Titer] in Serum

232

1652

1.41

5.95

1.2

—

(3042733) HLA Ab [Presence] in Serum

289

2.01

5.92

4.8

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

143

926

1.55

5.90

1.3

1.4

—

titre

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

115

708

1.63

5.86

2.0

2.7

571.03

515.59

e6/l

0.59

545

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

211

2.19

5.82

1.2

1.1

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

375

1.87

5.80

2.2

2.3

8.45

9.59

mg/l

0.94

324

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

553

1.71

5.71

1.1

0.80

9.15

nmol/l

1.68

103

(3016244) Insulin [Units/volume] in Serum or Plasma

125

792

1.59

5.68

3.2

3.4

29.14

26.30

mu/l

0.32

120

746

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

291

3862

0.75

5.67

1.1

0.61

ratio

0.04

430

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

2.76

5.61

1.4

1.7

0.49

2.12

mg/l

2.75

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

360

1.87

5.52

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

360

1.87

5.52

1.3

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

478

1.74

5.45

1.4

1.6

—

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

2.77

5.45

1.3

1.6

1.25

1.95

mg/l

0.71

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

2.77

5.45

1.3

1.6

0.23

1.17

mg/l

2.81

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

2.77

5.45

1.3

1.6

1.94

3.08

mg/l

0.62

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

2.77

5.45

1.3

1.6

3.18

4.10

mg/l

0.36

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

2.77

5.45

1.3

1.6

1.71

1.50

mg/l

0.06

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

2.77

5.45

1.3

1.6

1.03

2.80

mg/l

1.87

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

2.77

5.45

1.3

1.6

0.66

2.32

mg/l

2.28

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

2.77

5.45

1.3

1.6

1.73

1.76

mg/l

0.02

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

2.77

5.45

1.3

1.6

3.38

1.95

mg/l

0.41

(4027681) Cerebrospinal fluid IgG ratio and IgG index

109

677

1.62

5.40

1.3

1.2

0.60

0.63

ratio

0.22

400

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

120

764

1.58

5.37

1.2

108.87

114.88

pmol/l

0.66

120

764

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

252

2.03

5.36

1.5

1.3

118.74

121.66

nmol/l

0.05

185

(3006571) Granulocytes/Leukocytes in Synovial fluid

134

876

1.54

5.34

1.6

53.16

54.89

0.18

546

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

760

6410

1.20

5.33

3.2

2.6

71.29

71.83

ml/min/173m2

0.13

321

2652

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

116

735

1.59

5.30

1.1

282.11

290.86

mg/l

0.71

108

673

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

113

2.57

5.28

1.3

1.2

2.02

1.66

iu/ml

0.40

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1076

9357

1.17

5.27

4.8

4.5

31.85

32.43

1.03

813

6499

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

100

614

1.64

5.20

1.1

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

329

2531

1.31

5.20

1.8

38.77

41.75

nmol/l

1.15

323

2474

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

136

899

1.52

5.16

1.2

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

149

1004

1.49

5.16

1.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

3.34

5.15

1.2

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

128

837

1.54

5.11

1.7

1.9

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

450

3613

1.26

5.08

1.5

1.4

9.83

10.04

u/l

0.11

360

2885

(3006922) Hepatitis E virus Ab [Presence] in Serum

117

751

1.56

5.08

1.1

—

(3004451) EKG impression Narrative

385

1.80

5.07

1.4

1.3

—

(4035726) Immunohistochemistry procedure

819

6990

1.19

5.04

1.5

1.4

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

3.17

5.03

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

105

660

1.60

4.99

1.0

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

210

1521

1.39

4.95

1.9

1.7

479.95

375.82

mu/l

1.10

177

1220

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

531

4357

1.23

4.93

1.4

1.3

213.81

227.72

miu/ml

0.41

248

2121

(3000093) Morphology [Interpretation] in Blood Narrative

113

729

1.56

4.82

1.1

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

2.64

4.80

8.1

12.1

5.89

5.49

mmol/l

0.28

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

2.64

4.80

1.5

1.2

0.24

0.52

iu/ml

1.93

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

224

2.01

4.68

1.1

1.2

71.29

69.23

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

493

1.67

4.67

1.3

1.2

30.54

22.96

u/l

0.26

417

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

509

1.66

4.65

1.3

1.2

91.13

86.52

u/l

0.10

440

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

331

1.82

4.61

2.6

2.4

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

397

1.74

4.61

1.1

—

0.12

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

495

1.66

4.61

1.5

1.7

4.09

4.48

nmol/l

0.07

397

(40761539) Cells [Type] in Urine sediment by Light microscopy

172

2.16

4.60

1.2

1.1

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

310

1.84

4.59

2.4

2.0

12.00

122.40

ug/min

2.97

(3044242) Glucose [Moles/volume] in Arterial blood

369

1.77

4.55

3.5

2.0

7.71

7.98

mmol/l

0.26

369

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

2.61

4.55

2.8

3.1

1.45

1.37

mg/l

0.06

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

629

1.58

4.54

1.9

2.8

0.91

0.74

e9/l

1.95

608

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

491

1.65

4.49

1.3

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

123

823

1.50

4.47

1.4

1.3

4.24

5.66

umol/l

4.78

108

739

(3001964) Herpes simplex virus Ag [Presence] in Specimen

263

1.91

4.47

1.6

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

463

3788

1.23

4.46

1.6

1.7

4.84

4.27

mg/l

0.49

356

2794

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

125

841

1.49

4.43

1.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

278

1.87

4.43

1.1

1.2

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

140

964

1.46

4.42

1.3

1.5

8.44

7.85

mmol/l

0.97

134

933

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

501

1.64

4.41

1.3

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

236

1777

1.34

4.40

1.9

175.69

192.17

pmol/l

1.39

219

1681

(40768446) Kidney Pathology biopsy report

351

1.77

4.40

1.9

1.7

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

389

1.73

4.36

2.1

2.9

0.94

1.32

ug/l

0.99

367

(3028308) Erythrocytes [#/volume] in Pleural fluid

640

1.55

4.24

1.6

1.4

43235.28

69333.09

e6/l

0.56

352

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

372

1.73

4.17

1.2

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

471

1.64

4.15

1.2

—

(3039000) Anion gap in Blood by calculation

201

1492

1.35

4.14

6.0

7.1

11.50

11.29

mmol/l

0.37

183

1327

(3018572) Chloride [Moles/volume] in Blood

201

1493

1.35

4.13

6.0

7.1

105.26

105.34

mmol/l

0.08

183

1329

(3003329) Lymphocytes/Leukocytes in Synovial fluid

100

657

1.53

4.00

1.6

30.94

34.08

0.34

395

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

176

2.05

3.98

1.3

1.1

—

(3012441) Differential panel - Pleural fluid

619

1.54

3.95

1.6

1.5

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

112

756

1.49

3.95

1.0

1.1

—

(3009871) Measles virus Ab [Titer] in Serum

401

1.68

3.94

1.7

2596.92

3164.91

titre

0.27

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

225

1.91

3.94

1.1

1.2

94.60

82.68

—

(21494755) Public health laboratory ask at order entry panel

884

10047

0.87

3.90

1.3

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

2.88

3.89

1.6

1.2

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

328

1.74

3.87

1.0

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

241

1.87

3.86

1.6

10.47

9.00

ug/l

0.86

241

(3000060) B lymphocytes [#/volume] in Blood

390

1.67

3.81

1.7

2.5

0.24

0.26

e9/l

0.10

186

(3016750) Collection duration of Urine

372

1.67

3.65

2.4

2.3

512.74

500.98

min

0.38

288

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

3.11

3.64

1.2

2.5

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

266

2096

1.28

3.62

1.3

1.2

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

283

1.77

3.62

1.8

1.7

270.00

118.69

au/ml

—

(3004775) Volume in Urine collected for unspecified duration

490

1.58

3.59

2.5

2.3

729.38

620.23

0.66

343

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

137

2.12

3.54

1.3

1.4

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1059

9473

1.13

3.50

3.2

3.1

0.69

0.75

ug/l

1.48

695

5861

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

4.23

3.50

1.1

1.2

0.22

0.20

g/l

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

6.16

3.50

1.0

0.38

0.06

u/ml

—

(21494814) CD8 cells/Lymphocytes in Specimen

354

1.67

3.49

2.2

2.3

27.66

30.59

0.87

354

(3023199) Leukocytes [#/volume] in Pleural fluid

106

728

1.46

3.48

1.5

1.4

1668.89

3748.76

e6/l

0.97

507

(3020876) Protein [Mass/time] in 24 hour Urine

123

871

1.42

3.43

3.3

2.4

1.13

1.38

g/24h

0.73

511

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

119

2.19

3.43

1.2

1.3

101.08

67.09

ng/l

0.26

(3002621) Streptococcal DNAse B [Units/volume] in Serum

107

2.25

3.37

1.1

184.14

326.82

u/ml

—

(3042631) Mycobacterium sp identified in Specimen

125

892

1.41

3.35

3.1

2.8

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

483

1.56

3.35

1.1

2.18

12.64

u/ml

1.08

(3013637) Mi-2 Ab [Presence] in Serum

225

1.83

3.31

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

225

1.83

3.31

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

225

1.83

3.31

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

225

1.83

3.31

1.1

—

(3034988) Calcium [Moles/volume] in Capillary blood

169

1.96

3.27

1.6

3.7

1.17

1.19

mmol/l

1.09

158

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

121

863

1.41

3.26

1.2

60.79

66.17

u/l

0.33

100

766

(3017400) Magnesium [Moles/volume] in Urine

4.74

3.23

1.3

1.7

2.83

2.68

mmol/l

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

170

1.94

3.22

1.3

1.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

130

2.08

3.17

2.1

1.9

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

613

1.47

3.12

2.1

1.8

2.91

3.87

mg/l

3.28

596

(3012565) Volume of 24 hour Urine

413

1.58

3.10

2.1

2153.14

1959.15

0.67

383

(3017569) Oxygen content in Arterial blood

367

1.61

3.07

2.9

2.3

15.60

16.10

0.44

367

(3050129) First trimester maternal screen panel - Serum or Plasma

460

5390

0.85

3.07

1.4

1.5

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

478

1.53

3.06

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

626

1.46

3.01

1.1

1549.18

1489.21

miu/ml

0.22

626

(3020491) Glucose [Moles/volume] in Blood

626

1.46

3.01

1.6

1.9

6.68

6.21

mmol/l

0.82

468

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

196

1526

1.29

3.00

2.6

2.4

140.50

90.36

ug/min

0.79

117

935

(3024932) HLA-DR beta [Type]

285

1.69

3.00

1.0

1.1

—

(4015189) Microbial culture of sputum

161

1.93

2.98

2.1

2.3

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

678

1.43

2.96

1.4

1.5

125671.21

90472.14

e6/l

0.22

467

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

219

1.78

2.96

1.0

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

219

1.78

2.96

1.0

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

219

1.78

2.96

1.0

1.1

—

(40768795) Lymph node Pathology biopsy report

117

846

1.39

2.95

1.3

1.2

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

340

1.62

2.95

1.0

1.2

—

(3000012) Reticulocyte production index

131

966

1.36

2.93

2.7

2.1

0.85

0.89

0.33

628

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

3.25

2.92

1.0

0.94

2.67

u/ml

0.64

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.32

2.90

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

2.32

2.90

1.2

—

(3045788) Cell count panel - Pleural fluid

608

1.45

2.87

1.6

1.4

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

214

1.78

2.86

1.2

1.1

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

215

1.77

2.82

1.1

—

39.67

u/ml

—

(21494434) Karyotype in Bone marrow

652

1.43

2.81

1.3

1.2

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

284

1.66

2.77

2.4

2.8

28.90

28.17

umol/l

0.16

206

(3044927) Protein electrophoresis panel - Urine

654

1.43

2.77

1.2

1.1

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

3.91

2.77

1.0

1.1

23.29

36.34

umol/24h

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

269

1.68

2.77

1.5

2.0

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

269

1.68

2.77

1.5

2.0

—

(3024471) HLA-A [Type]

292

1.65

2.76

1.0

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1711

15901

1.09

2.76

5.4

5.2

2.16

2.51

ug/l

0.63

1548

14434

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

582

1.45

2.72

1.9

1.6

—

(40768806) Pleura Pathology biopsy report

617

1.43

2.68

1.5

1.6

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

272

1.66

2.67

3.4

2.8

0.62

0.61

mmol/l

0.60

272

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

103

744

1.39

2.65

1.3

1.5

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

2.33

2.64

1.1

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

183

1.81

2.64

1.2

318.27

294.33

pmol/l

0.12

136

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

273

1.65

2.63

1.5

2.0

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

360

1.56

2.60

1.5

1.4

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

141

1.92

2.59

3.4

3.0

74.49

22.18

mg/l

0.73

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

614

5416

1.14

2.58

3.1

3.3

39.40

50.70

u/ml

0.96

594

5246

(3002619) Bacteria identified in Specimen by Culture

222

1.71

2.56

1.2

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

590

1.43

2.55

1.2

—

(40768441) Liver Pathology biopsy report

649

1.41

2.54

1.5

—

(3008536) Aspergillus sp Ab [Presence] in Serum

171

1.82

2.53

1.6

2.4

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

144

1105

1.31

2.52

3.3

0.85

0.81

nmol/l

0.46

113

882

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

3.23

2.51

1.2

1.0

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.32

2.47

1.1

1.92

1.61

umol/24h

0.67

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

217

1.71

2.47

1.3

1.1

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

2.38

2.45

1.3

1.2

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

638

1.40

2.43

1.2

1.1

1.08

1.05

ratio

1.54

517

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

513

1.45

2.43

1.3

857.14

992.31

titre

0.40

104

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

257

1.64

2.41

1.0

1.1

15.00

37.47

iu/ml

5.67

257

(3024263) Appearance of Synovial fluid

377

1.51

2.36

1.5

1.8

—

(3003434) Protein [Mass/volume] in Pleural fluid

109

814

1.34

2.33

1.5

33.67

33.15

g/l

0.16

738

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

245

1.64

2.30

1.1

—

(3016038) Potassium [Moles/volume] in Urine

536

1.42

2.29

2.2

1.4

34.77

34.21

mmol/l

0.07

477

(3019174) dRVVT (LA screen)

2.12

2.28

1.1

1.2

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.12

2.28

1.0

1.1

—

(3006462) Nitrate [Presence] in Urine

389

1.49

2.26

2.5

2.9

—

(42528597) U1 small nuclear ribonucleoprotein C Ab [Presence] in Serum by Line blot

3.89

2.25

1.0

—

(3007919) Fasciola sp Ab [Titer] in Serum

3.89

2.25

1.0

—

(42528596) U1 small nuclear ribonucleoprotein A Ab [Presence] in Serum by Line blot

3.89

2.25

1.0

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

164

1.77

2.22

1.0

1.1

18.79

7.09

u/ml

0.42

164

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

675

1.37

2.22

1.3

1.4

11.06

11.63

umol/l

0.44

638

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

327

1.53

2.20

1.2

1.1

52.39

59.81

u/ml

0.35

319

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

114

1.93

2.19

2.5

2.0

—

(3028433) Virus identified in Specimen by Culture

273

1.58

2.16

1.1

1.2

—

(3034891) Synovial lining cells/cells in Synovial fluid

361

1.50

2.16

1.6

8.40

3.08

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

653

1.37

2.15

1.7

1.5

—

(3009677) Dengue virus Ab [Presence] in Serum

2.62

2.14

1.0

1.2

—

(3025130) Human papilloma virus identified in Specimen

236

1961

1.21

2.13

1.7

1.9

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

274

1.57

2.13

1.6

1.9

39.90

40.17

g/l

0.13

274

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

622

1.37

2.10

1.1

1.13

1.12

u/l

0.05

242

(3022493) Free Hemoglobin [Mass/volume] in Plasma

372

1.48

2.09

2.4

5.4

3643.07

65.98

mg/l

0.49

279

(3017704) Immunofixation for Urine

350

1.49

2.03

1.8

1.6

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

491

1.41

2.02

2.0

2.6

44.21

42.54

0.42

266

(3010375) cycloSPORINE [Mass/volume] in Blood

408

1.45

2.02

27.9

29.2

137.90

119.33

ug/l

0.96

335

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

347

4003

0.86

2.01

1.4

1.5

—

(3033086) Enterovirus Ab [Titer] in Serum

3.08

2.01

1.1

1.0

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

2.35

1.94

1.0

1.1

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

2.73

1.93

1.1

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

114

1.84

1.86

6.2

5.6

28.93

40.84

ug/min

0.65

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

483

1.39

1.85

1.3

124.04

180.09

pmol/l

1.88

483

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

182

1.65

1.84

1.0

1.1

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

230

1938

1.19

1.84

1.4

22.56

24.83

u/l

0.48

194

1589

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

183

1509

1.22

1.84

2.9

3.5

328.56

621.99

u/ml

0.68

164

1375

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

152

1.71

1.82

1.1

1.2

95.67

108.91

mg/l

0.04

110

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.57

1.80

1.0

1.1

—

(3024869) Neuronal Ab [Presence] in Serum

123

1.79

1.0

1.1

—

(3033099) Centromere Ab [Titer] in Serum

224

1.56

1.75

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

248

1.53

1.75

1.1

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

2.92

1.72

1.0

—

(3020393) Adenovirus Ag [Presence] in Stool

155

1.68

1.72

1.5

1.6

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

103

1.85

1.71

3.4

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

258

2999

0.86

1.70

1.5

55.64

59.68

ug/l

0.85

258

2999

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

242

1.53

1.69

1.1

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

500

1.36

1.69

1.3

1.2

9.21

9.26

mm/h

0.01

500

(4211845) Urine protein measurement

424

1.39

1.68

2.5

2.8

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

682

1.31

1.68

2.7

2.8

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

341

1.44

1.67

1.1

—

(44806420) Estimation of glomerular filtration rate

138

1119

1.24

1.66

2.5

2.3

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

513

1.35

1.62

1.5

1.7

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

205

1.56

1.61

1.2

1.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.84

1.61

2.6

2.7

—

(3032057) Clostridioides difficile [Presence] in Stool

143

1.68

1.60

1.4

1.9

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

222

1.53

1.58

1.1

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

3.00

1.58

4.2

7.2

—

(3007463) Buprenorphine [Presence] in Urine

2.20

1.56

9.5

5.1

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

807

8718

0.92

1.54

7.6

5.9

—

(36303858) Crystals [Presence] in Urine

3.33

1.52

1.4

1.1

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

177

1.58

1.51

2.3

2.5

1.83

1.61

mmol/l

0.16

130

(3012920) Ethanol [Mass/volume] in Serum or Plasma

2.86

1.50

1.0

1.4

1.78

2.05

g/l

—

(3036180) Methadone [Presence] in Urine

2.86

1.50

3.7

2.3

—

(40762365) Oxygen content in Arterial blood by calculation

108

1.76

1.50

3.6

2.5

15.25

14.73

ml/dl

0.26

(3037692) Legionella sp identified in Specimen by Organism specific culture

258

1.47

1.49

1.8

1.4

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

116

938

1.24

1.47

4.4

5.2

38.35

82.74

u/ml

1.58

319

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

334

1.41

1.47

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

340

3829

0.88

1.47

1.6

—

(3050794) Legionella sp Ab [Presence] in Serum

1.92

1.43

1.0

1.1

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

2.31

1.42

8.7

8.0

—

(3036670) Protein [Mass/volume] in Synovial fluid

204

1.52

1.42

1.1

1.3

39.57

39.06

g/l

0.06

101

(3014271) Vancomycin [Susceptibility]

278

1.44

1.41

2.9

2.8

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

141

1.63

1.41

1.6

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

388

1.37

1.40

1.6

1.80

3.19

u/field

1.12

275

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

175

1482

1.18

1.40

4.3

3.9

23.99

27.78

u/ml

0.53

167

1437

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

614

1.29

1.40

1.4

1.3

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

380

1.37

1.39

2.8

3.1

185.25

137.73

au/ml

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

380

1.37

1.39

1.2

1.1

47.60

246.99

ng/l

1.62

(3027874) Urate [Moles/volume] in Urine

2.61

1.36

1.0

2.11

1.78

mmol/l

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

2.61

1.36

2.3

6.1

—

(42528595) U1 small nuclear ribonucleoprotein 70kD Ab [Presence] in Serum by Line blot

2.94

1.36

1.0

—

(3036782) Glucose [Moles/volume] in Pleural fluid

635

1.28

1.35

1.3

1.4

7.40

6.26

mmol/l

2.12

595

(4146454) Self-monitoring of blood glucose

733

1.26

1.35

2.7

2.8

—

(3047189) Immunofixation for 24 hour Urine

298

1.41

1.34

2.6

1.8

—

(3005011) Chlamydia sp Ab [Titer] in Serum

151

1.59

1.34

1.6

1.5

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1334

12640

1.06

1.33

4.1

4.2

22.25

21.81

0.41

579

5805

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

418

1.34

1.33

1.3

13.18

12.19

u/l

0.20

387

(3027923) C peptide [Moles/volume] in Serum or Plasma

454

1.32

1.30

1.3

1.7

1.24

1.34

nmol/l

0.28

343

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

2.09

1.30

4.7

3.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.76

1.28

1.6

1.4

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

114

1.67

1.27

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

114

1.67

1.27

1.1

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

2.00

1.27

1.1

—

(40757494) Bilirubin.total [Moles/volume] in Blood

370

1.35

1.27

2.9

2.4

19.05

73.21

umol/l

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.79

1.26

1.1

1.3

—

(3014891) Appearance of Pleural fluid

1.86

1.23

1.5

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

565

1.28

1.22

1.8

2.0

1.70

1.67

u/field

0.02

304

(3006567) Chloride [Moles/time] in 24 hour Urine

2.63

1.21

1.0

1.1

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

495

1.29

1.21

1.7

1.6

3.36

6.01

u/l

2.74

408

(3052592) Norovirus Ag [Presence] in Stool

124

1.61

1.20

1.3

1.4

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

222

1.44

1.18

2.2

1.6

0.17

0.23

nmol/l

0.54

158

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.70

1.17

1.0

1.1

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

206

1.46

1.17

1.3

1.2

14.33

11.81

pmol/l

0.14

(3017509) Phencyclidine [Presence] in Urine

133

1.58

1.17

2.0

1.7

—

(40762887) Creatinine [Moles/volume] in Blood

1.93

1.16

1.4

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

1.16

0.0

8.8

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

749

1.23

1.15

1.4

1.5

38.34

1340.81

pmol/l

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

394

1.32

1.15

1.2

1.9

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

394

1.32

1.15

1.2

1.9

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

224

1.43

1.13

1.1

1.0

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

119

1.60

1.11

2.5

1.9

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

423

1.30

1.11

3.7

4.0

8.34

8.90

mg/l

0.33

341

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

503

1.27

1.10

2.1

1.5

3128125.20

1859150.74

iu/ml

—

(40762814) Titanium [Mass/volume] in Blood

1.67

1.09

3.0

2.4

2.48

4.28

ug/l

—

(3006270) Folate [Moles/volume] in Blood

602

1.25

1.08

1.1

356.60

388.71

nmol/l

0.78

538

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

1.87

1.07

6.0

5.2

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

255

2275

1.12

1.06

1.6

1.5

0.47

0.43

nmol/l

0.15

190

1788

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

435

1.29

1.06

1.0

95.30

91.52

0.34

345

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

123

0.49

1.04

10.8

7.2

80.67

70.22

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

2.06

1.02

1.3

1.0

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

2.00

1.00

9.4

5.1

—

(3020650) Glucose [Presence] in Urine

346

1.30

0.94

1.6

0.00

0.03

estimate

1.34

346

(3028717) Thiamine [Mass/volume] in Blood

133

1.50

0.94

1.3

1.2

59.75

62.77

ug/l

0.37

133

(3040893) Potassium [Moles/volume] in Capillary blood

2.22

0.93

1.2

2.8

4.23

4.52

mmol/l

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

117

1.54

0.93

1.4

1.6

—

(3041806) Other cells [#/volume] in Blood by Manual count

555

0.77

0.92

1.7

1.5

0.57

0.50

e9/l

0.72

555

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

209

1.39

0.92

2.1

1.6

0.34

0.40

ug/l

0.43

149

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

147

1281

1.15

0.91

1.6

1.3

47.08

30.99

u/l

0.49

134

1105

(3029612) Listeria sp Ab [Titer] in Serum

2.14

0.91

1.7

1.2

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

2.14

0.91

1.5

1.2

319.17

298.50

nmol/l

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

591

1.22

0.89

1.5

1.3

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

111

949

1.17

0.89

1.1

—

(3046861) Legionella sp Ag [Presence] in Urine

1.86

0.87

1.0

—

(3007733) Chloride [Moles/volume] in Urine

2.00

0.87

4.0

1.4

98.17

75.28

mmol/l

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.82

0.85

13.1

8.4

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

112

1.52

0.84

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

180

1.39

0.81

9.8

7.2

6.43

5.31

kpa

1.04

180

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

122

1.48

0.79

1.6

1.2

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

107

1.50

0.76

1.2

1.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1120

11658

0.96

0.75

1.9

1.8

3.44

3.41

ratio

0.38

823

8628

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

773

8118

0.95

0.75

1.5

1.6

946.16

1003.27

mu/l

1.10

642

6916

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

133

1.43

0.73

1.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

100

1.50

0.72

1.1

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

159

1.38

0.72

1.0

85.44

72.22

ug/l

0.85

136

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

845

8841

0.95

0.71

1.6

3.36

3.45

mmol/l

1.48

559

5861

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

214

2350

0.91

0.71

1.3

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.58

0.71

1.4

1.8

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

1.71

0.69

3.0

4.4

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

1.51

0.69

3.1

3.8

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

118

1.44

0.69

1.0

—

(40765096) Chromosome analysis panel by Banding

239

1.30

0.68

1.2

1.1

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

179

1.34

0.66

1.7

1.4

0.23

0.25

mmol/l

—

(3013336) Amino acids [Identifier] in Serum or Plasma

1.61

0.65

2.0

2.6

—

(40768793) Breast Pathology biopsy report

262

2419

1.09

0.64

1.3

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

120

1.42

0.64

5.6

7.6

10.47

10.53

0.04

120

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

477

1.20

0.64

1.2

1.3

62.20

70.13

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

104

1.44

0.62

1.1

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

402

0.80

0.61

7.6

6.2

120.44

9407.34

u/ml

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

1.67

0.61

1.2

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.48

0.60

1.0

1.1

88.62

87.27

titre

0.02

(37021550) Renin [Units/volume] in Plasma --upright

174

1.32

0.59

1.2

1.3

126.00

108.22

mu/l

0.06

137

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.54

0.59

1.5

1.7

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

259

2409

1.08

0.56

1.3

1.4

84.83

131.23

pmol/l

2.35

252

2348

(3029396) Erythrocyte agglutination [Presence] in Blood

430

1.19

0.55

3.6

3.1

—

(40757373) Influenza virus identified in Isolate

142

1.34

0.54

2.0

1.6

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

1090

0.89

0.54

1.4

1.5

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

100

1.40

0.51

1.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

306

1.21

0.50

4.7

3.4

1.08

1.27

0.39

306

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.43

0.49

1.0

1.1

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.56

0.48

1.0

1.3

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

110

1.36

0.48

1.3

1.0

—

(4281824) Cell count and differential, peritoneal fluid

107

965

1.11

0.48

1.1

1.2

—

(3043410) Blood group antigens tested for on Red Blood Cells

217

1.24

0.47

1.8

1.7

—

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

265

0.79

0.45

2.0

1.7

—

215.80

—

(3032868) Hemoglobin electrophoresis panel in Blood

103

1.36

0.45

1.8

1.5

—

(3044007) Cell count panel - Peritoneal fluid

228

1.23

0.45

1.9

2.0

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

128

0.70

0.43

1.2

1.3

6.09

5.65

mmol/l

—

128

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

113

1.33

0.42

1.4

18.60

14.00

nmol/l

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

131

1.30

0.42

1.0

1.1

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.36

0.41

12.0

6.0

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

150

1.27

0.40

1.2

55.92

364.64

ug/l

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

1.34

0.39

2.4

2.8

1.94

3.24

mg/l

1.80

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.41

0.39

1.0

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

115

1.30

0.38

2.3

1.8

—

(3034426) Prothrombin time (PT)

316

1.17

0.38

1.3

1.2

28.51

28.12

0.12

316

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

1.39

0.38

1.0

1.2

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.39

0.38

1.8

1.1

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

1.35

0.37

1.0

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

564

1.12

0.35

5.9

7.3

33.10

84.36

ug/l

0.67

373

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

0.64

0.35

2.8

2.3

1.80

0.69

u/field

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

1.30

0.33

1.0

1.7

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

1.30

0.33

1.2

1.0

7.29

8.40

mmol/l

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

307

0.85

0.33

1.2

51.50

70.58

ug/l

1.89

307

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.35

0.31

7.1

1.8

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

475

1.12

0.31

2.0

1.9

—

(3001556) Androgen free Index in Serum or Plasma

138

1.23

0.30

1.2

1.1

—

(3041672) Baker's yeast Ab [Presence] in Serum

1.33

0.30

1.0

1.1

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

402

1.12

0.28

2.4

2.5

46.21

50.98

umol/l

0.48

363

(3051101) Glucose [Moles/volume] in Cord blood

103

1.26

0.28

5.8

6.3

7.91

7.99

mmol/l

0.05

103

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.29

0.28

1.0

1.1

9.25

13.66

u/l

—

(3006598) pH of Arterial cord blood

205

0.83

0.28

1.0

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

337

1.13

0.27

1.5

14.70

14.67

pmol/l

0.01

288

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

461

1.11

0.27

1.1

1.2

24.22

18.76

u/l

0.36

415

(3005532) Lymphocytes/Leukocytes in Pleural fluid

204

0.83

0.26

1.5

51.67

62.76

0.50

170

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

193

0.83

0.26

1.1

1.3

—

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

104

1.25

0.26

1.8

1.7

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.26

0.26

1.2

1.1

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.30

0.26

1.0

1.1

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

226

1.15

0.24

1.1

1.2

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

464

1.10

0.24

1.1

1.2

92.44

74.90

u/l

0.89

417

(3026692) Albumin [Mass/volume] in Peritoneal fluid

189

1.16

0.24

1.4

14.23

12.88

g/l

0.27

142

(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid

1.32

0.23

1.0

1.1

0.02

0.03

mg/l

—

(3049233) Organic acids panel - Urine

1.32

0.23

1.0

1.3

—

(40768800) Prostate Pathology biopsy report

104

980

1.06

0.22

1.2

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

157

1644

0.95

0.22

4.4

3.3

24.01

25.97

mg/l

0.33

105

1100

(46236302) HLA-C [Type] by High resolution typing

1.22

0.22

1.0

—

(40760409) HLA-A [Type] by High resolution

1.22

0.22

1.0

—

(40763590) HLA-DQ beta [Type]

1.22

0.22

1.0

—

(40760410) HLA-B [Type] by High resolution

1.22

0.22

1.0

—

(3013862) HLA-DP [Type]

1.19

0.21

1.0

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.21

0.0

1.0

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

0.21

0.0

1.0

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

0.00

0.21

0.0

1.0

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.21

0.0

1.1

—

0.26

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

348

3582

0.97

0.21

1.5

1.6

—

(40758292) HTLV I+II Ab panel - Serum

173

1.16

0.20

1.3

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

145

1.17

0.20

1.6

1.4

—

(3001019) Free T4 and TSH panel - Serum or Plasma

586

5736

1.02

0.20

1.8

1.7

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.20

0.0

1.8

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.22

0.20

1.0

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

860

1.06

0.19

5.0

4.2

43.86

53.81

u/ml

0.18

855

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

192

1852

1.04

0.18

1.7

1.8

—

(1761868) Lipid panel - Serum or Plasma

3578

35993

0.99

0.17

3.1

2.8

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

343

3515

0.97

0.17

1.5

—

(3026726) Creatinine [Moles/volume] in Specimen

0.71

0.16

2.0

2.7

465.00

460.28

umol/l

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

101

1.19

0.16

1.2

1.3

3.48

1.66

mmol/l

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

263

1.10

0.16

2.1

2.2

1430.00

917.29

e6/l

0.29

185

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

422

0.92

0.16

1.2

1.1

—

(3025577) Chromium [Mass/volume] in Blood

360

1.08

0.16

2.4

2.2

1.40

2.61

ug/l

2.94

304

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

216

1.11

0.15

2.1

1.6

—

(3035880) pH of Pleural fluid

313

1.09

0.15

1.3

7.42

7.40

0.24

206

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

227

1.10

0.14

2.2

1.9

24282.31

15072.66

e6/l

0.23

119

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

103

1.17

0.13

1.2

1.5

46.00

58.63

—

(3005033) Fetal Nuchal fold Thickness US

336

3429

0.98

0.13

1.4

1.5

1.27

1.26

0.14

244

2523

(3039443) Prostate specific Ag panel - Serum or Plasma

101

970

1.04

0.13

1.7

1.6

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

231

2255

1.02

0.12

1.3

1.4

3.52

3.68

ug/l

0.11

215

2059

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

200

1.10

0.12

1.1

1.3

55.92

39.56

0.82

132

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

1.09

0.09

1.0

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

174

1.09

0.09

2.5

4.6

223.47

66.70

u/l

0.43

169

(3011325) HIV 1+2 Ab [Presence] in Serum

1.04

0.09

1.0

1.1

0.08

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

141

1376

1.02

0.09

1.3

1.4

7.20

6.93

mmol/l

0.48

126

1240

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

126

1.11

0.09

1.0

1.1

1.03

1.34

mom

1.20

126

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.11

0.09

1.2

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

1.11

0.09

1.7

1.4

494.52

548.93

nmol/l

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.11

0.09

1.0

1.1

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

1.07

0.08

22.2

6.5

102.00

102.04

g/l

—

(4034850) Laboratory test

243

2471

0.98

0.08

10.1

9.1

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

1.05

0.08

1.5

1.1

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

1.03

0.08

2.2

3.3

—

0.00

estimate

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.83

0.08

1.2

1.5

42.92

24.04

nmol/l

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

1.03

0.07

1.1

1.4

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

286

0.94

0.07

2.3

2.7

130.69

118.70

ng/l

0.17

168

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.07

0.07

1.0

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

152

0.92

0.06

3.9

3.0

420.50

2953.30

u/l

1.57

141

(1617658) Protocol used for examination of sentinel lymph nodes

689

0.97

0.06

1.1

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

425

4288

0.99

0.06

1.4

1.5

1.20

1.19

ratio

0.04

259

2613

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

425

4288

0.99

0.06

1.4

1.5

0.94

0.95

ratio

0.07

256

2597

(3032352) Blasts [#/volume] in Cerebral spinal fluid

121

0.91

0.06

1.2

3.8

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

424

4277

0.99

0.06

1.4

1.5

1.16

1.15

ratio

0.06

255

2585

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

199

1.06

0.04

1.1

1.3

—

(40765089) Chromosome analysis panel - Blood by G-banded

433

0.97

0.04

1.0

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

160

0.94

0.04

1.5

2.7

4.87

43.05

ug/l

0.81

160

(3045462) Protein/Creatinine [Ratio] in Urine

180

1.06

0.04

4.3

4.9

2311.51

63.49

mg/mmol

0.47

164

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

462

0.97

0.03

1.0

317.53

323.80

ng/l

0.06

331

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

418

4204

0.99

0.03

1.4

1.5

—

(3010937) Rubella virus Ab [Presence] in Serum

1.09

0.03

1.3

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

416

4138

1.01

0.03

1.5

—

(44806071) Cardiolipin IgM antibody measurement

152

1.05

0.02

1.0

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

451

4522

1.00

0.01

1.5

59.18

61.83

ug/l

0.59

380

3804

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

467

0.98

0.01

1.0

45.92

42.34

ng/l

0.23

328

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.06

0.01

1.0

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

124

1.05

0.00

1.2

1.34

1.67

mmol/l

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

200

1.00

0.00

1.4

2.0

1.97

2.34

ug/l

0.34

116

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

219

1.00

0.00

2.5

2.6

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

127

1.02

0.00

1.0

—

(3000034) Microalbumin [Mass/volume] in Urine

633

1.00

0.00

2.8

2.9

44.64

57.14

mg/l

0.26

466

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

209

1.00

0.00

1.3

1.2

—

(4133840) Spirometry

218

1.01

0.00

1.1

1.2

—

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

207

1.01

0.00

5.6

6.5

7.57

8.72

0.80

207

(40761995) Spermatozoa Progressive [#/volume] in Semen

207

1.01

0.00

2.8

3.3

41.81

44.35

0.26

207

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

464

0.99

0.00

1.0

700.45

747.57

ng/l

0.44

322

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.04

0.00

1.0

1.1

—

(3025830) Chlamydophila pneumoniae IgM Ab [Units/volume] in Serum

0.00

0.0

1.0

—

28.00

—

(3008896) Cortisol [Moles/volume] in Urine

0.00

0.0

1.0

—

279.00

—

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

0.00

0.0

1.0

—

19.67

—

(3033463) Neutrophils [#/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3020399) Glucose [Mass/volume] in Urine

0.00

0.0

2.0

—

0.06

—

(4212803) Bone marrow aspirate examination

0.88

0.00

1.0

1.1

—

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

0.0

1.1

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.1

—

(3038413) Eosinophils/Leukocytes in Peritoneal dialysis fluid by Manual count

0.00

-0.00

0.0

8.2

—

15.00

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

0.99

-0.00

1.0

1.2

13.90

10.65

mg/l

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

0.00

-0.00

0.0

1.2

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3028468) Fragments [Presence] in Blood by Light microscopy

0.00

-0.00

0.0

1.0

—

(3004560) Lymphocytes [#/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.93

-0.00

1.0

170.57

163.80

g/l

—

(3012787) Ethosuximide [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

2.4

—

331.60

—

(3022475) Manganese [Moles/volume] in Blood

0.98

-0.00

1.3

0.14

0.16

umol/l

—

(3018910) Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.1

—

47.27

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.85

-0.00

2.4

1.6

323.40

313.41

umol/24h

—

(3034459) Mononuclear cells/Leukocytes in Pleural fluid

0.91

-0.00

1.2

1.4

68.83

73.24

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(36031836) Tocilizumab [Mass/volume] in Serum

0.00

-0.00

0.0

1.6

—

28.00

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: ST19_ADVER_EFFEC_NOT_ELSEW_CLASSIFIED – Adverse effects, not elsewhere classified

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Adverse effects, not elsewhere classified

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Adverse effects, not elsewhere classified (ST19_ADVER_EFFEC_NOT_ELSEW_CLASSIFIED)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints